Law Viewer

Back Home

INFECTIOUS DISEASE CONTROL AND PREVENTION ACT

Wholly Amended by Act No. 9847, Dec. 29, 2009

Amended by Act No. 9932, Jan. 18, 2010

Act No. 10789, Jun. 7, 2011

Act No. 11439, May 23, 2012

Act No. 11645, Mar. 22, 2013

Act No. 12444, Mar. 18, 2014

Act No. 13392, Jul. 6, 2015

Act No. 13474, Aug. 11, 2015

Act No. 13639, Dec. 29, 2015

Act No. 14286, Dec. 2, 2016

Act No. 14316, Dec. 2, 2016

Act No. 15183, Dec. 12, 2017

Act No. 15534, Mar. 27, 2018

Act No. 15608, Apr. 17, 2018

Act No. 16101, Dec. 31, 2018

Act No. 16725, Dec. 3, 2019

Act No. 17067, Mar. 4, 2020

Act No. 17472, Aug. 11, 2020

Act No. 17475, Aug. 12, 2020

Act No. 17491, Sep. 29, 2020

Act No. 17642, Dec. 15, 2020

Act No. 17689, Dec. 22, 2020

Act No. 17653, Dec. 22, 2020

Act No. 17893, Jan. 12, 2021

Act No. 17920, Mar. 9, 2021

Act No. 18507, Oct. 19, 2021

Act No. 18603, Dec. 21, 2021

Act No. 18744, Jan. 11, 2022

Act No. 18893, Jun. 10, 2022

Act No. 19213, Jan. 17, 2023

Act No. 19290, Mar. 28, 2023

Act No. 19419, May 19, 2023

Act No. 19441, Jun. 13, 2023

Act No. 19603, Aug. 8, 2023

Act No. 19644, Aug. 16, 2023

Act No. 20090, Jan. 23, 2024

CHAPTER I GENERAL PROVISIONS
 Article 1 (Purpose)
The purpose of this Act is to contribute to improving and maintaining citizens' health by preventing the occurrence and epidemic of infectious diseases hazardous to citizens' health, and prescribing necessary matters for the prevention and control thereof.
 Article 2 (Definitions)
The terms used in this Act are defined as follows: <Amended on Jan. 18, 2010; Mar. 22, 2013; Mar. 18, 2014; Jul. 6, 2015; Dec. 2, 2016; Mar. 27, 2018; Dec. 3, 2019; Mar. 4, 2020; Aug. 11, 2020; Dec. 15, 2020; Jun. 13, 2023; Aug. 8, 2023>
1. The term "infectious disease" means any infectious disease classified in Class 1 infectious diseases, Class 2 infectious diseases, Class 3 infectious diseases, Class 4 infectious diseases, parasitic diseases, infectious diseases under surveillance by the World Health Organization, infectious diseases spread through bioterrorism, sexually transmitted infectious diseases, zoonoses, and nosocomial infectious diseases;
2. The term "Class 1 infectious disease" means any of the following infectious diseases spread through bioterrorism or infectious diseases with a high mortality rate or a high risk of mass outbreak, requiring immediate reporting on the outbreak or epidemic thereof as well as high-level isolation, such as negative pressure isolation: Provided, That Class 1 infectious diseases shall include infectious diseases designated by the Commissioner of the Korea Disease Control and Prevention Agency in consultation with the Minister of Health and Welfare as they are predicted to be suddenly transmitted into or epidemic in the Republic of Korea and require urgent prevention and control:
(a) Ebola virus disease;
(b) Marburg hemorrhagic fever;
(c) Lassa fever;
(d) Crimean-Congo hemorrhagic fever;
(e) South American hemorrhagic fever;
(f) Rift Valley fever;
(g) Smallpox;
(h) Pest;
(i) Anthrax;
(j) Botulism;
(k) Tularemia;
(l) Emerging infectious disease syndrome;
(m) Severe Acute Respiratory Syndrome (SARS);
(n) Middle East Respiratory Syndrome (MERS);
(o) Animal influenza infection in humans;
(p) Novel influenza;
(q) Diphtheria;
3. The term "Class 2 infectious disease" means any of the following infectious diseases that shall be reported within 24 hours of outbreak or epidemic in consideration of the possibility of transmission and require isolation: Provided, That Class 2 infectious diseases shall include infectious diseases designated by the Commissioner of the Korea Disease Control and Prevention Agency in consultation with the Minister of Health and Welfare as they are predicted to be suddenly transmitted into or epidemic in the Republic of Korea and require urgent prevention and control:
(a) Tuberculosis;
(b) Varicella;
(c) Measles;
(d) Cholera;
(e) Typhoid;
(f) Paratyphoid;
(g) Shigellosis;
(h) Colon bacillus infection with enterorrhagia;
(i) Hepatitis A;
(j) Pertussis;
(k) Mumps;
(l) Rubella;
(m) Poliomyelitis;
(n) Meningococcal meningitis;
(o) Haemophilus influenzae type B;
(p) Streptococcus pneumoniae infection;
(q) Hansen’s disease (Leprosy);
(r) Scarlet fever;
(s) Vancomycin Resistant Staphylococcus Aureus (VRSA);
(t) Carbapenem-resistant Enterobacteriaceae (CRE);
(u) Hepatitis E;
4. The term "Class 3 infectious disease" means any of the following infectious diseases that shall be reported within 24 hours of outbreak or epidemic as the outbreak thereof requires continuous surveillance: Provided, That Class 3 infectious diseases shall include infectious diseases designated by the Commissioner of the Korea Disease Control and Prevention Agency in consultation with the Minister of Health and Welfare as they are predicted to be suddenly transmitted into or epidemic in the Republic of Korea and require urgent prevention and control:
(a) Tetanus;
(b) Hepatitis B;
(c) Japanese encephalitis;
(d) Hepatitis C;
(e) Malaria;
(f) Legionellosis;
(g) Vibrio vulnificus sepsis;
(h) Epidemic typhus;
(i) Murine typhus;
(j) Scrub typhus;
(k) Leptospirosis;
(l) Brucellosis;
(m) Rabies;
(n) Hemorrhagic fever with renal syndrome;
(o) Acquired immunodeficiency syndrome (AIDS);
(p) Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD);
(q) Yellow fever;
(r) Dengue fever;
(s) Q fever;
(t) West Nile fever;
(u) Lyme disease (Lyme borreliosis);
(v) Tick-borne encephalitis;
(w) Melioidosis;
(x) Chikungunya fever;
(y) Severe fever with thrombocytopenia syndrome (SFTS);
(z) Zika virus infection;
(aa) Syphilis;
5. The term "Class 4 infectious disease" means any of the following infectious diseases that require sentinel surveillance to investigate whether they are epidemic, other than Classes 1 through 3 infectious diseases: Provided, That infectious diseases designated by the Commissioner of the Korea Disease Control and Prevention Agency shall be included:
(a) Influenza;
(b) Deleted; <Aug. 8, 2023>
(c) Ascariasis;
(d) Trichuriasis;
(e) Enterobiasis;
(f) Clonorchiasis;
(g) Paragonimiasis;
(h) Fasciolopsis buski;
(i) Hand, foot and mouth disease;
(j) Gonorrhea;
(k) Chlamydia infection;
(l) Chancroid;
(m) Genital herpes;
(n) Condyloma acuminata;
(o) Vancomycin-resistant Enterococci (VRE) infection;
(p) Methicillin-resistant Staphylococcus aureus (MRSA) infection;
(q) Multidrug-resistant Pseudomonas aeruginosa (MRPA) infection;
(r) Multidrug-resistant Acinetobacter baumannii (MRAB) infection;
(s) Norovirus infection;
(t) Acute respiratory infection;
(u) Imported parasite disease;
(v) Enterovirus infection;
(w) Human papilloma virus infection;
6. The term "parasitic disease" means any infectious disease publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, among those spread by parasite infection;
7. Deleted. <Mar. 27, 2018>
8. The term "infectious disease under surveillance by the World Health Organization" means any infectious disease designated to be subject to surveillance by the World Health Organization to prepare for international public health emergencies, as publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency;
9. The term "infectious disease spread through bioterrorism" means any infectious disease publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, among those spread by pathogens either deliberately used or for terrorism, etc.;
10. The term "sexually transmitted infectious disease" means any infectious disease publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, among those transmitted by sexual contact;
11. The term "zoonosis" means any infectious disease publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, among those spread by pathogens transmittable from animals to humans and vice-versa;
12. The term "nosocomial infectious disease" means any infectious disease that occurs to patients, expecting mothers, etc. in the course of undergoing medical activities, which is publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency as it requires surveillance;
13. The term "patient of an infectious disease" means a person whose body has been affected by the infectious pathogens to indicate relevant symptoms and whose case has been confirmed through a diagnosis by a physician, dentist, or oriental medical doctor according to the diagnosis standards referred to in Article 11 (6), or through a laboratory test by an institution for confirming infectious pathogens referred to in Article 16-2;
14. The term "probable patient of an infectious disease" means a person suspected of being affected by the infectious pathogens who has yet to be confirmed as a patient of an infectious disease;
15. The term "pathogen carrier" means a person who has no clinical symptoms but carries the infectious pathogens;
15-2. The term "person suspected of contracting an infectious disease" means any of the following:
(a) A person (hereinafter referred to as "contact") who comes into contact with or is suspected of coming into contact with a patient or probable patient of an infectious disease or pathogen carrier (hereinafter referred to as "patient of an infectious disease, etc.");
(b) A person who has stayed in, or passed through, a quarantine inspection required area or strict quarantine inspection required area defined in subparagraph 7 or 8 of Article 2 of the Quarantine Act, and may have contracted an infectious disease;
(c) A person who has been exposed to risk factors, such as infectious pathogens, and may have contracted an infectious disease;
16. The term "surveillance" means the complete processes of systematically and continuously collecting, analyzing, and interpreting data on the outbreak of infectious diseases, and the infectious pathogens and vectors thereof, of timely distributing the findings thereof to those who need such findings, and of using such findings for the prevention and control of infectious diseases;
16-2. The term "sentinel surveillance" means conducting regular and continuous medical monitoring by designating a surveillance agency for the outbreak of infectious diseases of relatively low disease severity, for which conducting a total inspection is difficult due to high incidence rates;
17. The term "epidemiological investigation" means the activities of investigating the number of cases involving patients of an infectious disease, etc. and of tracing the sources of their infection, etc., if such cases occur, in order to contain such infectious diseases and to prevent their spread, and the activities of examining the causes of adverse reactions, if such cases occur after vaccinations have been taken against infectious diseases or if it is unclear whether a disease is infectious but it is necessary to investigate the cause thereof;
18. The term "adverse reaction to a vaccination" means any symptom or disease that may be caused by a vaccination, which is related to such vaccination in terms of time;
19. The term "high-risk pathogen" means the infectious pathogens determined by Ministerial Decree of Health and Welfare, which could cause a serious threat to citizens' health if used for biological terrorism or leaked to the outside due to accidents, etc.;
20. The term "overseas emerging infectious disease subject to control" means any infectious disease designated by the Commissioner of the Korea Disease Control and Prevention Agency in consultation with the Minister of Health and Welfare, which is caused by a variant or coproma of an existing pathogen, or a new pathogen, unknown to science, giving rise to a new health problem internationally, and which requires countermeasures against transmission into the Republic of Korea;
21. "Medical and quarantine supplies" means the products and equipment designated by the Commissioner of the Korea Disease Control and Prevention Agency as necessary for medical treatment and quarantine, such as medicine and quasi-drugs defined in Article 2 of the Pharmaceutical Affairs Act and medical devices defined in Article 2 of the Medical Devices Act.
 Article 3 (Relationship to Other Statutes)
Except as otherwise provided in other statutes, this Act shall apply to the prevention and control of infectious diseases.
 Article 4 (Responsibilities of the State and Local Governments)
(1) The State and local governments shall respect the dignity and values of patients of an infectious disease, etc. as human beings, protect their fundamental rights, and shall not impose on them any disadvantage, such as restrictions on employment, except by statutes.
(2) The State and local governments shall perform the following projects for preventing and controlling infectious diseases: <Amended on Mar. 18, 2014; Jul. 6, 2015; Mar. 4, 2020; Dec. 15, 2020>
1. Preventive and control measures against infectious diseases;
2. Medical treatment and protection of patients of an infectious disease, etc.;
3. Formulation and implementation of plans for vaccination for the prevention of infectious diseases;
4. Education and publicity concerning infectious diseases;
5. Collection, analysis, and provision of information on infectious diseases;
6. Investigation and research on infectious diseases;
7. Collection, testing, preservation, and control of infectious pathogens (including specimens, such as blood, body fluids, and tissues, for identifying infectious pathogens), and the surveillance of drug resistance thereof;
8. Training of specialized human resources for the prevention and control, etc. of infectious diseases;
8-2. Protection of specialized human resources who have performed duties for preventing, controlling, etc. infectious diseases;
9. International cooperation for the exchange, etc. of infectious disease control information;
10. Stockpiling of medical and quarantine supplies for the treatment and prevention of infectious diseases;
11. Evaluation of programs for the prevention and control of infectious diseases;
12. Investigation and research on the occurrence of infectious diseases caused by factors affecting demographic changes, such as climate change, low birth rate, and aging population, and the formulation of preventive measures;
13. Support for corporations or associations which perform duties for prevention and treatment of Hansen's disease;
14. Establishment and operation of an information system for the prevention and control of infectious diseases;
15. Formulation of a plan, education, and training for preparing against the transmission of overseas emerging infectious diseases into the Republic of Korea;
16. Continuous monitoring of the trends of outbreaks of overseas emerging infectious diseases, and the risk evaluation thereof, and the designation of overseas emerging infectious diseases subject to control;
17. Preparation of a system for prevention from and countermeasures against overseas emerging infectious diseases subject to control, and the publication of reports and the public notice of the relevant guidelines (including manuals) on such overseas emerging infectious diseases, through the collection of information on pathogens, etc. thereof, the analysis of characteristics thereof, and research thereon.
(3) The State and local governments (including superintendents of education) shall share information on infectious diseases and information on situations of the outbreak and prevalence thereof and mutually cooperate in order to efficiently treat such diseases and prevent the spread thereof. <Added on Jul. 6, 2015>
(4) The State and local governments shall share the relevant information with medical institutions and medical personnel's associations prescribed in the Medical Service Act in order to monitor and prevent the outbreak of infectious diseases. <Added on Jul. 6, 2015>
 Article 5 (Responsibilities and Rights of Medical Personnel)
(1) Medical personnel, the heads of medical institutions, etc. prescribed in the Medical Service Act shall have the right to be provided information on the medical treatment of patients of infectious diseases, and may be compensated for any loss caused by the diagnosis, treatment, etc., of patients of infectious diseases.
(2) Medical personnel, the heads of medical institutions, etc. prescribed in the Medical Service Act shall make utmost effort for the diagnosis, management, treatment, etc., of patients of infectious diseases, and shall actively cooperate to comply with administrative orders issued by the Minister of Health and Welfare, the Commissioner of the Korea Disease Control and Prevention Agency, or the heads of local governments. <Amended on Aug. 11, 2020>
(3) Medical personnel, the heads of medical institutions, etc. prescribed in the Medical Service Act shall actively cooperate with the State and local governments that perform the affairs of the surveillance of outbreak, prevention, and control of infectious diseases, and epidemiological investigations.
[This Article Wholly Amended on Jul. 6, 2015]
 Article 6 (Rights and Obligations of Citizens)
(1) Where each citizen is isolated or quarantined and medically treated due to an infectious disease, he or she may be compensated for any loss caused by such isolation and medical treatment. <Amended on Jul. 6, 2015>
(2) Each citizen shall have the right to know information on the situation of the outbreak of infectious diseases and the prevention and control of infectious diseases and how to cope therewith, and the State and local governments shall promptly disclose the relevant information. <Amended on Jul. 6, 2015>
(3) Each citizen shall have the right to receive the diagnosis and medical treatment of any infectious disease under this Act at a medical institution, and the State and local governments shall bear expenses incurred therein. <Added on Jul. 6, 2015>
(4) Each citizen shall actively cooperate with the State and local governments that perform activities for the prevention and control of infectious diseases, such as treatment and isolation or quarantine measures. <Added on Jul. 6, 2015>
[Title Amended on Jul. 6, 2015]
CHAPTER II MASTER PLANS AND PROJECTS
 Article 7 (Formulation of Plans for Prevention and Control of Infectious Diseases)
(1) The Commissioner of the Korea Disease Control and Prevention Agency shall formulate and implement in consultation with the Minister of Health and Welfare a master plan for preventing and controlling infectious diseases (hereinafter referred to as "master plan") for every five years. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(2) A master plan shall include the following: <Amended on Jul. 6, 2015; Mar. 4, 2020; Dec. 15, 2020; Mar. 9, 2021>
1. Basic objectives of and direction-setting for implementing the prevention and control of infectious diseases;
2. Plans for projects for preventing and controlling major infectious diseases, and methods of implementation;
2-2. Matters regarding stockpiling and managing medical and quarantine supplies, etc. in preparation for an infection disease;
3. Schemes for nurturing infectious disease specialists;
3-2. Schemes for strengthening the capabilities of each medical institution by type, prescribed in each subparagraph of Article 3 (2) of the Medical Service Act, to respond to emergencies with respect to infectious diseases;
4. Schemes for managing information on infectious diseases by utilizing statistics of infectious diseases, information and communications technologies, etc.;
5. Schemes for sharing information related to infectious diseases among medical institutions;
6. Other matters necessary for preventing and controlling infectious diseases.
(3) The Special Metropolitan City Mayor, a Metropolitan City Mayor, a Special Self-Governing City Mayor, a Do Governor, a Special Self-Governing Province Governor (hereinafter referred to as "Mayor/Do Governor"), and the head of a Si/Gun/Gu (referring to the head of an autonomous Gu; hereinafter the same shall apply) shall formulate and implement an implementation plan, based on a master plan. <Amended on Jun. 13, 2023>
(4) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may request relevant administrative agencies or associations to provide data necessary for formulating and implementing master plans or implementation plans under paragraph (3). <Amended on Jan. 18, 2010; Aug. 11, 2020>
(5) The head of a relevant administrative agency or association in receipt of a request under paragraph (4) shall comply therewith unless there is a compelling reason not to do so.
 Article 8 (Operation of Organizations Supporting Infectious Disease Control Projects)
(1) The Commissioner of the Korea Disease Control and Prevention Agency and a Mayor/Do Governor may establish an organization supporting infectious disease control projects which consists of private professionals, etc. in order to support the implementation of mater plans and implementation plans under Article 7 and international cooperation affairs, etc. <Amended on Jan. 18, 2010; Aug. 11, 2020; May 19, 2023>
(2) The State and a local government may subsidize a necessary budget for the operation, etc. of an organization supporting infectious disease control projects.
(3) Matters necessary for the establishment, operation, support, etc. of an organization supporting infectious disease control projects under paragraphs (1) and (2) shall be prescribed by Presidential Decree.
 Article 8-2 (Infectious Disease Hospitals)
(1) The State shall establish, or operate by designation, the Central Infectious Disease Hospital, equipped with adequate facilities, personnel, and research capabilities to pursue research and prevention of infectious diseases, to nurture and train infectious disease specialists, and to diagnose and treat patients of infectious diseases. <Amended on Aug. 16, 2023>
(2) For the medical examination and treatment of patients with infectious diseases, the State shall establish or designate and operate regional specialized hospitals for infectious diseases in each region, which are equipped with the number of sickbeds (including negative pressure isolation rooms and isolation beds) in a scale not below the standards prescribed by Ministerial Decree of Health and Welfare. In such cases, the State shall set up the region in consideration of the population, geographical accessibility, etc. <Amended on Oct. 19, 2021; Aug. 16, 2023>
(3) The State may provide budget support for establishing, or operating by designation, the Central Infectious Disease Hospital or a regional infectious disease hospital under paragraph (1) or (2), within the budget. <Amended on Aug. 16, 2023>
(4) The State may establish the Clinical Committee for Infectious Diseases at the Central Infectious Disease Hospital under paragraph (1) in order to provide advice, etc. on the business affairs of the Central Infectious Disease Hospital. <Added on Aug. 16, 2023>
(5) Procedures necessary for and methods of establishing, or operating by designation, the Central Infectious Disease Hospital or a regional infectious disease hospital under paragraph (1) or (2), and details of support therefor shall be prescribed by Presidential Decree. <Amended on Aug. 16, 2023>
[This Article Added on Dec. 29, 2015]
 Article 8-3 (Measures for Controlling Resistant Bacteria)
(1) For the prevention of breakout, spread, etc. of resistant bacteria, the Minister of Health and Welfare shall formulate and promote measures for controlling resistant bacteria through deliberations by the Infectious Disease Control Committee prescribed in Article 9 every five years.
(2) The measures for controlling resistant bacteria shall include objectives and directions of policy, matters to prevent the spread of resistant bacteria, such as the improvement of medical environment, matters concerning the reinforcement of monitoring system, and other matters recognized to be necessary for measures for controlling resistant bacteria.
(3) Matters necessary for procedures for formulating measures for controlling resistant bacteria, etc. shall be prescribed by Presidential Decree.
[This Article Added on Dec. 2, 2016]
 Article 8-4 (Cooperation in Business)
(1) For the formulation and implementation of measures for controlling resistant bacteria, the Minister of Health and Welfare may listen to the opinions of the relevant public officials or relevant experts or request the relevant institutions, organizations, etc. to render cooperation, such as submission of necessary materials.
(2) To prepare measures for controlling resistant bacteria, the Minister of Health and Welfare may request the heads of the relevant central administrative agencies to render necessary cooperation, such as submitting materials or opinions on the objectives and directions of the measures for controlling resistant bacteria.
(3) Any person who receives a request for cooperation prescribed in paragraphs (1) and (2) shall comply therewith unless there is good cause.
[This Article Added on Dec. 2, 2016]
 Article 8-5 (Emergency Operations Center)
(1) The Commissioner of the Korea Disease Control and Prevention Agency shall establish and operate a standing (24/7) Emergency Operations Center to collect and disseminate information on infectious diseases, manage the situation, and take initial measures and command in emergencies where infectious diseases are transmitted into or epidemic in the Republic of Korea. <Amended on Aug. 11, 2020>
(2) Matters necessary for the establishment and operation of the Emergency Operations Center under paragraph (1) shall be prescribed by Presidential Decree.
[This Article Added on Mar. 27, 2018]
 Article 8-6 (Support for Research and Development of Infectious Diseases)
(1) For the survey and research of infectious diseases, the Commissioner of the Korea Disease Control and Prevention Agency may formulate plans for research and development regarding infectious diseases and implement projects of research and development of medicines, vaccine, and others. In such cases, the Commissioner of the Korea Disease Control and Prevention Agency may pay contributions to the institutions or organizations conducting research and development projects, for the expenses incurred in such research, within the budget.
(2) For the survey and research under paragraph (1), the Commissioner of the Korea Disease Control and Prevention Agency may designate a specialized institution or revoke the designation thereof pursuant to subparagraph 4 of Article 2 of the National Research and Development Innovation Act, as prescribed by Ministerial Decree of Health and Welfare.
(3) The Health and Medical Service Technology Promotion Act shall apply mutatis mutandis to matters necessary for the payment, use, and management of contributions under paragraph (1) and the designation, operation, etc. of specialized institutions under paragraph (2).
(4) The Commissioner of the Korea Disease Control and Prevention Agency may conduct testing and analysis for the development of medicines and vaccines for infectious diseases at the request of the research institutes, universities, enterprises, etc. related to the development of medicines and vaccines for infectious diseases, as prescribed by Ministerial Decree of Health and Welfare.
(5) Any person who requests the testing and analysis pursuant to paragraph (4) shall pay fees, as prescribed by Ministerial Decree of Health and Welfare.
[This Article Wholly Amended on May 19, 2023]
 Article 9 (The Infectious Disease Control Committee)
(1) An Infectious Disease Control Committee (hereinafter referred to as the "Committee") shall be established under the Korea Disease Control and Prevention Agency to deliberate on major policies on the prevention and control of infectious diseases. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(2) The Committee shall deliberate on the following: <Amended on Mar. 18, 2014; Dec. 2, 2016; Dec. 3, 2019; Dec. 15, 2020; Mar. 9, 2021; Jun. 10, 2022>
1. Formulation of master plans;
2. Provision of medical services related to infectious diseases;
3. Investigation and research on infectious diseases;
4. Dissemination of knowledge concerning the prevention, control, etc. of infectious diseases, and the enhancement of the human rights of patients of an infectious disease, etc.;
5. Matters concerning autopsy orders issued under Article 20;
6. Matters concerning standards for and methods of conducting vaccinations under Article 32 (3);
6-2. Matters concerning the preemptive stockpiling and long-term purchase of vaccines used for mandatory vaccination services referred to in Article 24 and special vaccination services referred to in Article 25 (hereinafter referred to as "mandatory vaccines, etc.") pursuant to Article 33-2 (1);
6-3. Determining the distribution criteria, such as the priority of supplying mandatory vaccines, etc. prescribed in Article 33-2 (2), and other necessary matters;
7. Formulation and implementation of crisis control measures against infectious diseases under Article 34;
8. Matters concerning the preemptive stockpiling, long-term purchase, and production of preventive and therapeutic medical and quarantine supplies under Article 40 (1) and (2);
8-2. Determination of the distribution standards, including priority in supplying medical and quarantine supplies (limited to drugs under the Pharmaceutical Affairs Act and medical devices under the Medical Devices Act) under Article 40-2, and other necessary matters;
8-3. Matters concerning contracts necessary for the purchase and supply of vaccines or drugs in development under Article 40-6;
9. Matters concerning compensation by the State for injury caused by vaccination, etc. under Article 71;
10. Matters concerning measures for controlling resistant bacteria;
11. Other matters concerning the prevention and control of infectious diseases, which are referred by the Chairperson of the Committee to its meeting.
 Article 10 (Composition of Commission)
(1) The Committee shall be comprised of not more than 30 members, including one Chairperson and one Vice-Chairperson. <Amended on Mar. 27, 2018>
(2) The Commissioner of the Korea Disease Control and Prevention Agency shall be the Chairperson; the Vice-Chairperson shall be appointed by the Chairperson, from among its members; and its members shall be appointed or commissioned by the Chairperson, from among the following persons. In such cases, non-public official members shall constitute a majority of all members: <Amended on Jan. 18, 2010; Dec. 29, 2015; Mar. 27, 2018; Dec. 3, 2019; Aug. 11, 2020; Jan. 12, 2021>
1. Public officials in charge of duties of preventing and controlling infectious diseases;
2. Medical personnel specializing in infectious diseases or infectious disease control;
3. Persons with expertise related to infectious diseases;
4. Persons recommended by a consultative council of Mayors/Do Governors prescribed in Article 182 of the Local Autonomy Act;
5. Persons recommended by a non-profit, non-governmental organization defined in Article 2 of the Assistance for Non-Profit, Non-Governmental Organizations Act;
6. Persons with considerable knowledge and experience in infectious diseases.
(3) Advisory committees by field, comprised of the members of the Committee and external experts, may be established to efficiently perform the duties of the Committee.
(4) Except as provided in paragraphs (1) through (3), matters necessary for the composition, operation, etc. of the Committee and advisory committees shall be prescribed by Presidential Decree.
CHAPTER III REPORTING
 Article 11 (Reporting by Physicians)
(1) Where any of the following cases (excluding cases caused by a Class 4 infectious disease subject to sentinel surveillance under Article 16 (6)) occurs, a physician, dentist, or oriental medical doctor shall report such fact to the head of the medical institution to which he or she belongs, and shall instruct the relevant patient and his or her cohabitants how to prevent infection determined by the Commissioner of the Korea Disease Control and Prevention Agency: Provided, That a physician, dentist, or oriental medical doctor who does not belong to a medical institution shall report such fact to the director of the competent public health center: <Amended on Jan. 18, 2010; Dec. 29, 2015; Mar. 27, 2018; Mar. 4, 2020; Aug. 11, 2020>
1. Where he or she diagnoses a patient of an infectious disease, etc. or examines the corpse of such patient, etc.;
2. Where he or she diagnoses a person indicating an adverse reaction to a vaccination, or examines the corpse of such person;
3. Where a patient of an infectious disease, etc. dies of any infectious disease falling under Classes 1 through 3 infectious diseases;
4. Where a person suspected as a patient of an infectious disease refuses infectious pathogen testing.
(2) Where a staff member of an institution for confirming infectious pathogens referred to in Article 16-2 discovers a patient of an infectious disease, etc. prescribed by Ministerial Decree of Health and Welfare through a laboratory test, etc., he or she shall report such fact to the head of the relevant institution. <Amended on Jul. 6, 2015; Mar. 27, 2018; Mar. 4, 2020>
(3) Upon receipt of a report under paragraph (1) or (2), the head of a medical institution and the head of an institution for confirming infectious pathogens referred to in Article 16-2 shall report thereon to the Commissioner of the Korea Disease Control and Prevention Agency or the director of the competent public health center, immediately in cases of Class 1 infectious diseases, within 24 hours in cases of Classes 2 and 3 infectious diseases, and within seven days in cases of Class 4 infectious diseases, respectively. <Added on Jul. 6, 2015; Mar. 27, 2018; Mar. 4, 2020; Aug. 11, 2020>
(4) Where any case falling under any subparagraph of paragraph (1) (excluding any case caused by a Class 4 infectious disease subject to sentinel surveillance under Article 16 (6)) occurs, a military doctor serving in the Army, Navy, Air Force, or a unit under the direct control of the Ministry of Defense, shall report such fact to the commander of the unit to which he or she belongs, and the commander of the unit in receipt of such report shall report thereon to the director of the competent public health center, immediately in cases of Class 1 infectious diseases, and within 24 hours in cases of Classes 2 and 3 infectious diseases. <Amended on Jul. 6, 2015; Dec. 29, 2015; Mar. 27, 2018>
(5) Where any case falling under paragraph (1) 1 or 3 occurs due to a Class 4 infectious disease subject to sentinel surveillance under Article 16 (6), an institution of sentinel surveillance of infectious diseases referred to in Article 16 (1) shall report thereon to the Commissioner of the Korea Disease Control and Prevention Agency or the director of the competent public health center, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jul. 6, 2015; Dec. 29, 2015; Mar. 27, 2018; Aug. 11, 2020>
(6) Matters necessary for standards for diagnosing patients of infectious diseases, etc. methods and procedures for reporting, etc. under paragraphs (1) through (5) shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jul. 6, 2015>
 Article 12 (Other Persons Obligated to Report)
(1) Upon the outbreak of an infectious disease determined by Ministerial Decree of Health and Welfare that is among Classes 1 through 3 infectious diseases, any of the following persons shall request a physician, dentist, or oriental medical doctor to perform a diagnosis or an autopsy, or report it to the director of a public health center having jurisdiction over the relevant location: <Amended on Jan. 18, 2010; Jul. 6, 2015; Mar. 27, 2018; Dec. 15, 2020>
1. In an ordinary family, the cohabiting householder: Provided, That where the householder is absent, a member of the household;
2. In a school, social welfare facility, hospital, government office, company, entertainment place, chapel, means of transportation, such as vessel, aircraft, and train, business office or place of business, restaurant, accommodation, or any other place determined by Ministerial Decree of Health and Welfare where many people gather, its manager, executive, or representative;
3. Pharmacists, oriental medicine pharmacists, and pharmacy founders under the Pharmaceutical Affairs Act.
(2) If a person detects a patient of an infectious disease, etc. or a person suspected of having died of any infectious disease, regardless of whether the person is obligated to report under paragraph (1), the person shall notify the director of the competent public health center thereof.
(3) Matters necessary for the methods and period of reporting as prescribed in paragraph (1), methods and procedures for notification as prescribed in paragraph (2), and other relevant matters shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jul. 6, 2015>
 Article 13 (Reporting by Directors of Public Health Centers)
(1) The director of a public health center in receipt of a report made under Articles 11 and 12 shall report the details thereof to the competent Special Self-Governing City Mayor or Special Self-Governing Province Governor, or the head of the competent Si/Gun/Gu; and the Special Self-Governing City Mayor or the Special Self-Governing Province Governor shall report the same to the Commissioner of the Korea Disease Control and Prevention Agency, and the head of the Si/Gun/Gu to the competent Mayor/Do Governor, respectively.<Amended on Jan. 18, 2010; Aug. 11, 2020; Jun. 13, 2023>
(2) Upon receipt of a report referred to in paragraph (1), the Commissioner of the Korea Disease Control and Prevention Agency, the competent Mayor/Do Governor, or the head of the competent Si/Gun/Gu may require a person falling under Article 11 (1) 4 (limited to persons suspected of contracting any Class 1 infectious disease) to undergo infectious pathogen testing. <Added on Mar. 4, 2020; Aug. 11, 2020>
(3) Matters necessary for methods and procedures to report pursuant to paragraph (1), and other relevant matters, shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 4, 2020>
[Title Amended on Mar. 4, 2020]
 Article 14 (Notification of Zoonoses)
(1) Upon receipt of a report referred to in Article 11 (1) 2 of the Act on the Prevention of Contagious Animal Diseases, the head of the national animal disease control agency, the head of a Si/Gun/Gu having jurisdiction over the place where animals subject to reporting are located, or the head of a City/Do animal disease control agency shall immediately notify the Commissioner of the Korea Disease Control and Prevention Agency of contagious animal diseases prescribed in that Act, if they fall under any of the following: <Amended on Dec. 3, 2019; Aug. 11, 2020>
1. Anthracnose;
2. Highly pathogenic avian influenza;
3. Rabies;
4. Other zoonoses prescribed by Presidential Decree.
(2) The Commissioner of the Korea Disease Control and Prevention Agency notified under paragraph (1) shall take appropriate measures under this Act to prevent infectious diseases and the spread thereof. <Added on Jul. 6, 2015; Aug. 11, 2020>
(3) No head of an administrative agency in receipt of a report or notification made under paragraph (1) shall disclose the identity of the reporting person externally if such person asks him or her not to do so. <Amended on Jul. 6, 2015>
(4) Matters necessary for methods and procedures for notification prescribed in paragraph (1), and other relevant matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jul. 5, 2015>
 Article 15 (Detection and Management of Patients of Infectious Disease)
Where the director of a public health center receives a report under Articles 11 and 12 on any patient of an infectious disease, etc. who lives in his or her jurisdiction, he or she shall record such patient, etc. in a register and maintain the register (including electronic documents), as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
CHAPTER IV SURVEILLANCE OF INFECTIOUS DISEASES, EPIDEMIOLOGICAL INVESTIGATION
 Article 16 (Sentinel Surveillance of Infectious Diseases)
(1) The Commissioner of the Korea Disease Control and Prevention Agency may designate a health and medical service institution or any other institution or organization under the Framework Act on Health and Medical Services, as an institution of sentinel surveillance of infectious diseases, in consideration of the characteristics of a disease and the region of the outbreak thereof in order to ensure sentinel surveillance on the outbreak of infectious diseases. <Amended on Jan. 18, 2010; Dec. 3, 2019; Aug. 11, 2020>
(2) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may request the head of an institution of sentinel surveillance of infectious diseases designated under paragraph (1) (hereinafter referred to as "sentinel surveillance institution") to submit necessary data in connection with the sentinel surveillance of infectious diseases, or to provide necessary cooperation for the prevention and control of infectious diseases. In such cases, a sentinel surveillance institution shall comply therewith unless there is a compelling reason not to do so. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(3) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall provide relevant institutions, organizations, establishments, or citizens with important information on national health collected under paragraph (2). <Amended on Jan. 18, 2010; Aug. 11, 2020>
(4) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may subsidize sentinel surveillance institutions for expenses incurred in sentinel surveillance activities. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(5) The Commissioner of the Korea Disease Control and Prevention Agency may revoke the designation of a sentinel surveillance institution, where it falls under any of the following subparagraphs: <Amended on Jul. 6, 2015; Dec. 3, 2019; Aug. 11, 2020>
1. Where it fails to comply with a request to submit data or provide cooperation referred to in paragraph (2);
2. Where it is unable to conduct sentinel surveillance affairs on infectious diseases due to business closure, etc.;
3. In other cases prescribed by Ministerial Decree of Health and Welfare, including where it is negligent in performing sentinel surveillance affairs on infectious diseases.
(6) Infectious diseases subject to sentinel surveillance under paragraph (1) shall be Class 4 infectious diseases, and matters necessary for the designation of sentinel surveillance institutions and causes for revoking such designation shall be prescribed by Ministerial Decree of Health and Welfare. <Added on Jul. 6, 2015; Mar. 27, 2018>
(7) If deemed urgently necessary to obtain information related to the likelihood of the outbreak or epidemic of any infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency may request the head of a public institution prescribed by Presidential Decree among public institutions under the Act on the Management of Public Institutions, to provide such information. In such cases, the head of the public institution requested to provide such information shall comply with such request unless there is a compelling reason not to do so. <Amended on Jul. 6, 2015; Aug. 11, 2020>
(8) Matters necessary for the details of, procedures for, and treatment of information to be provided pursuant to paragraph (7) shall be prescribed by Presidential Decree. <Amended on Jul. 6, 2015>
 Article 16-2 (Institutions for Confirming Pathogens of Infectious Diseases)
(1) Any of the following institutions (hereinafter referred to as "institution for confirming infectious pathogens") may confirm infectious pathogens through laboratory testing, etc.: <Amended on Aug. 11, 2020; May 19, 2023>
1. The Korea Disease Control and Prevention Agency;
2. Centers for Disease Control and Prevention;
3. Public health and environment research institutes defined in Article 2 of the Public Health and Environment Research Institute Act;
4. Public health clinics defined in Article 10 of the Regional Public Health Act;
5. Medical institutions having a full-time medical specialist in diagnostic laboratory medicine, among the medical institutions prescribed in Article 3 of the Medical Service Act;
6. Medical schools having a diagnostic laboratory medicine department, among the medical schools established under Article 4 of the Higher Education Act;
7. The Korean National Tuberculosis Association (limited to cases of testing the pathogens of tuberculosis patients) established under Article 21 of the Tuberculosis Prevention Act;
8. Institutions (limited to cases of testing the pathogens of Hansen’s disease patients) established for the purpose of supporting treatment and rehabilitation of Hansen's disease patients, etc. under Article 32 of the Civil Act;
9. Institutions having a full-time medical specialist in diagnostic laboratory medicine, among the institutions entrusted by the State, local governments, medical institutions, etc. with the duties of examining specimens taken from the human body.
(2) The Commissioner of the Korea Disease Control and Prevention Agency may evaluate and manage the laboratory testing capability of institutions for confirming infectious pathogens to ensure the accuracy and reliability of their testing results of infectious pathogens. <Amended on Aug. 11, 2020>
(3) Matters necessary for the methods and procedures for evaluating and managing the laboratory testing capability of institutions for confirming infectious pathogens referred to in paragraph (2), and other relevant matters shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Mar. 4, 2020]
 Article 17 (Investigations into Actual Conditions)
(1) The Commissioner of the Korea Disease Control and Prevention Agency and Mayors/Do Governors shall conduct fact-finding surveys to understand the actual conditions of management of and infection by infectious diseases and the actual conditions of resistant bacteria, and publicize the outcomes of such surveys. <Amended on Jan. 18, 2010; Jul. 6, 2015; Dec. 2, 2016; Mar. 4, 2020; Aug. 11, 2020>
(2) With respect to surveys referred to in paragraph (1), the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor may request the heads of relevant institutions, corporations, or organizations, including medical institutions, to submit necessary data or statement of opinions. In such cases, any person in receipt of such request shall comply therewith unless there is good cause. <Added on Mar. 4, 2020; Aug. 11, 2020>
(3) Matters necessary for specifics included in fact-finding surveys under paragraph (1); the timing, methods, and procedures for conducting fact-finding surveys and the publication of the outcomes thereof; and other relevant matters, shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 4, 2020>
 Article 18 (Epidemiological Investigations)
(1) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu deems that an infectious disease breaks out and is likely to be epidemic subsequently or that it is unclear whether a disease is infectious but it is necessary to investigate the cause thereof, he or she shall, without delay, conduct an epidemiological investigation and then provide information concerning the findings thereof to the relevant medical institutions to a necessary extent: Provided, That if necessary for preventing the prevalence of the infectious disease in other areas, such information shall be provided to other medical institutions. <Amended on Jul. 6, 2015; Dec. 3, 2019; Aug. 11, 2020>
(2) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall establish an epidemiological investigation team to conduct an epidemiological investigation, respectively. <Amended on Aug. 11, 2020>
(3) No one shall commit any of the following acts in the course of an epidemiological investigation conducted by the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu: <Amended on Jul. 6, 2015; Aug. 11, 2020>
1. Refusing, obstructing, or evading the epidemiological investigation without good cause;
2. Making a false statement or presenting false materials;
3. Intentionally omitting or concealing any fact.
(4) Matters necessary for the details and timing and methods of conducting epidemiological investigations prescribed in paragraph (1), and the composition, duties, etc. of epidemiological investigation teams prescribed in paragraph (2) shall be prescribed by Presidential Decree.
 Article 18-2 (Request for Epidemiological Investigations)
(1) Where an infectious disease or any disease unknown for its cause has broken out or is likely to break out, medical personnel or the head of a medical institution prescribed in the Medical Service Act may request the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor to conduct an epidemiological investigation under Article 18. <Amended on Aug. 11, 2020>
(2) The Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor in receipt of a request prescribed in paragraph (1) shall notify, without delay, the relevant medical personnel or the founder of the relevant medical institution of whether to conduct an epidemiological investigation, the ground therefor, and other relevant matters. <Amended on Aug. 11, 2020>
(3) Matters necessary for requests for conducting an epidemiological investigation under paragraph (1), and the methods, procedures, etc. for notification made under paragraph (2) shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Jul. 6, 2015]
 Article 18-3 (Fosterage of Personnel for Epidemiological Investigations)
(1) The Commissioner of the Korea Disease Control and Prevention Agency may regularly provide education and training on epidemiological investigations to epidemiological investigation officers under Article 60-2 or epidemiological investigation officer trainees. <Amended on Mar. 4, 2020; Aug. 11, 2020; May 19, 2023>
(2) The courses of education and training tailored to each group of epidemiological investigation officers and epidemiological officer trainees under paragraph (1) and other necessary matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on May 19, 2023>
[This Article Added on Jul. 6, 2015]
 Article 18-4 (Request for Presentation of Materials and Other Relevant Matters)
(1) To efficiently conduct epidemiological investigations, etc. under Article 18, the Commissioner of the Korea Disease Control and Prevention Agency may require the head of a relevant central administrative agency and an institution or organization, etc. prescribed by Presidential Decree to present materials necessary for epidemiological investigations. <Amended on Aug. 11, 2020>
(2) Where a crisis alert of attention level or higher under Article 38 (2) of the Framework Act on the Management of Disasters and Safety is issued in connection with an infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor may request a corporation, organization, individual, etc. to submit materials necessary for epidemiological investigations to efficiently conduct epidemiological investigations under Article 18. <Added on May 19, 2023>
(3) Where the Commissioner of the Korea Disease Control and Prevention Agency conducts epidemiological investigations under Article 18, he or she may, if necessary, request the head of a relevant central administrative agency to provide necessary assistance, such as dispatch of the personnel belonging to such agency. <Amended on Aug. 11, 2020; May 19, 2023>
(4) A person in receipt of a request for the presentation of materials under paragraphs (1) and (2) and a request, etc. for assistance under paragraph (3) shall comply therewith, unless there is a compelling reason not to do so. <Amended on May 19, 2023>
(5) Matters necessary for the extent and methods of requests for the presentation of materials under paragraphs (1) and (2), and requests, etc. for assistance under paragraph (3), shall be prescribed by Presidential Decree. <Amended on May 19, 2023>
[This Article Added on Jul. 6, 2015]
 Article 18-5 (Provision of Infectious Disease Education)
(1) The heads of State agencies and the heads of local governments shall provide public officials, employees, etc. under their control with education about the prevention and control of infectious diseases and response to crisis (hereinafter referred to as "infectious disease education") at least once a year, and submit the results thereof to the Commissioner of the Korea Disease Control and Prevention Agency.
(2) The head of a public institution under Article 4 of the Act on the Management of Public Institutions may provide infectious disease education to executive officers and employees under his or her jurisdiction.
(3) The Commissioner of the Korea Disease Control and Prevention Agency shall develop and disseminate relevant curriculum to effectively provide infectious disease education under paragraphs (1) and (2).
(4) Matters necessary for the subject, scope, contents, and method of infectious disease education under paragraphs (1) and (2) and the development and dissemination of curriculum under paragraph (3) shall be prescribed by Presidential Decree.
[This Article Added on Sep. 14, 2023]
 Article 19 (Medical Examination)
A person engaged in any occupation prescribed by Ministerial Decree of Health and Welfare that requires a medical examination to prevent sexually transmitted infectious diseases, and a person infected by a sexually transmitted infectious disease and deemed by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor, or the head of a Si/Gun/Gu as highly likely to transmit the infection thereof, shall undergo a medical examination for sexually transmitted infectious diseases, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jun 13, 2023>
 Article 20 (Autopsy Orders)
(1) Where the Commissioner of the Korea Disease Control and Prevention Agency deems impracticable to identify whether a person suspected of having died of an infectious disease posing a potentially serious threat to national health has actually been died of the infectious disease, and to ascertain the cause of his or her death without conducting an autopsy, he or she may order an autopsy. <Amended on Aug. 11, 2020>
(2) An autopsy under paragraph (1) shall be conducted with consent from a relative defined in subparagraph 16 of Article 2 of the Act on Funeral Services (where a person with priority entitlement stipulated under each item of that subparagraph does not exist, a relative refers to a person with subordinate entitlement; hereinafter referred to as "relative"): Provided, That an autopsy order may be issued without consent from a relative, under extenuating circumstances that make it impracticable to obtain prior consent from a relative, such as unknown whereabouts and no contact details, and delay in the autopsy is deemed likely to make it impossible to achieve the purposes of the autopsy, which is preventing infectious diseases and protecting national health.
(3) The Commissioner of the Korea Disease Control and Prevention Agency shall designate an infectious disease specialist, or a person specializing in anatomy, pathology, or forensic medicine, as a physician in charge of an autopsy to require him or her to conduct the autopsy. <Amended on Aug. 11, 2020>
(4) Autopsies under paragraph (3) shall be conducted at facilities satisfying the biological safety level determined and publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency for each group of infectious disease, with which the deceased is suspected of being infected. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(5) Matters necessary for the designation of physicians in charge of autopsies, standards for facilities to be equipped for each type of infectious disease, management of relevant corpses under paragraph (3), and other relevant matters shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 20-2 (Methods of Conducting Funeral for the Deceased)
(1) In cases of death of a patient of an infectious disease, etc. (including a person confirmed after his or her death to have contained infectious pathogens), the Commissioner of the Korea Disease Control and Prevention Agency may restrict the methods of conducting funeral, etc. for the deceased, within necessary limits, for quarantining and preventing the spread of the infectious disease. <Amended on Aug. 11, 2020>
(2) Where the Commissioner of the Korea Disease Control and Prevention Agency intends to impose restrictions under paragraph (1), he or she shall provide explanations to the bereaved of the deceased on the necessity of the relevant measures and the detailed methods, process, etc. thereof. <Amended on Aug. 11, 2020>
(3) The Commissioner of the Korea Disease Control and Prevention Agency may request the installer or manager of a crematory facility to cooperate in taking measures under paragraph (1), and the installer or manager of the crematory facility in receipt of such request shall fully cooperate therein. <Amended on Aug. 11, 2020>
(4) The targets, methods, and process for restrictions imposed under paragraph (1), and other necessary matters, shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Dec. 29, 2015]
CHAPTER V HIGH-RISK PATHOGENS
 Article 21 (Reporting on Extraction, Distribution and Transfer, or Transfer of High-Risk Pathogens)
(1) A person who has extracted a high-risk pathogen from a patient of an infectious disease, food, animal/plant, or any other environment shall, without delay, report to the Commissioner of the Korea Disease Control and Prevention Agency on the name of the high-risk pathogen, the name of the object from which the pathogen has been extracted, the date and time of extraction, etc. <Amended on Jan. 18, 2010; Dec. 3, 2019; Aug. 11, 2020>
(2) A person who intends to have a high-risk pathogen distributed and transferred shall report to the Commissioner of the Korea Disease Control and Prevention Agency on the name of the high-risk pathogen, its distribution and transfer plan, etc. in advance. <Added on Dec. 3, 2019; Aug. 11, 2020>
(3) A person who intends to have a high-risk pathogen transferred shall report to the Commissioner of the Korea Disease Control and Prevention Agency on the name of the high-risk pathogen, its transfer plan, etc. in advance. <Added on Dec. 3, 2019; Aug. 11, 2020>
(4) Upon receipt of any report prescribed in paragraphs (1) through (3), the Commissioner of the Korea Disease Control and Prevention Agency shall review the report, and accept it if it is in compliance with this Act. <Added on Mar. 4, 2020; Aug. 11, 2020>
(5) Upon receipt of a report on the extraction of a high-risk pathogen pursuant to paragraph (1), the Commissioner of the Korea Disease Control and Prevention Agency may conduct an on-site inspection. <Added on Dec. 3, 2019; Mar. 4, 2020; Aug. 11, 2020>
(6) A person who possesses or controls high-risk pathogens shall prepare records on the current status of possession of such high-risk pathogens on an annual basis and submit them to the Commissioner of the Korea Disease Control and Prevention Agency. <Added on Mar. 27, 2018; Dec. 3, 2019; Mar. 4, 2020; Aug. 11, 2020>
(7) Matters necessary for methods and procedures for reporting prescribed in paragraphs (1) through (3) and the preparation and submission of records prescribed in paragraph (6), and other relevant matters shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 27, 2018; Dec. 3, 2019; Mar. 4, 2020>
[Title Amended on Mar. 27, 2018; Dec. 3, 2019]
 Article 22 (Permission for Introduction of High-Risk Pathogens)
(1) A person who intends to introduce high-risk pathogens into the Republic of Korea for the purposes of diagnosis of, academic research, etc. on infectious diseases shall obtain permission therefor from the Commissioner of the Korea Disease Control and Prevention Agency by satisfying the following requirements: <Amended on Jan. 18, 2010; Dec. 3, 2019; Aug. 11, 2020; Oct. 19, 2021>
1. The person shall install and operate the facilities handling high-risk pathogens referred to in Article 23 (1), or enter into a contract for the use of the facilities handling high-risk pathogens with a person who establishes and operates the facilities;
2. The person shall formulate a plan for safely transporting high-risk pathogens and emergency measures;
3. The person shall designate a manager in exclusive charge of high-risk pathogens, satisfying the requirements prescribed by Ministerial Decree of Health and Welfare.
(2) A person who intends to modify any of the matters permitted under paragraph (1) shall obtain permission therefor from the Commissioner of the Korea Disease Control and Prevention Agency: Provided, That where the person intends to modify any minor matter prescribed by Presidential Decree, he or she shall report such modification to the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(3) Where a person who has obtained permission for introducing high-risk pathogens into the domestic environment under paragraph (1) intends to transfer the relevant high-risk pathogens after acquiring them, he or she shall designate a place to acquire them, as prescribed by Presidential Decree, and report, in advance, a transfer plan to the Commissioner of the Korea Disease Control and Prevention Agency pursuant to Article 21 (1). In such cases, the Commissioner of the Korea Disease Control and Prevention Agency shall review the details of the plan, and accept it if it is in compliance with this Act. <Amended on Jan. 18, 2010; Mar. 4, 2020; Aug. 11, 2020>
(4) Where a person who has obtained permission pursuant to paragraph (1) falls under any of the following subparagraphs, the Commissioner of the Korea Disease Control and Prevention Agency may revoke the permission: Provided, That the Commissioner must revoke such permission if the person falls under subparagraph 1 or 2: <Added on Oct. 19, 2021>
1. Where the person has obtained permission by fraud or other improper means;
2. Where the person fails to report on acquisition under paragraph (3) within one year from the date of obtaining permission;
3. Where the person fails to fulfill the requirements referred to in paragraph (1).
(5) Matters necessary for the methods and procedures for granting permission, filing report, or revoking permission under paragraphs (1) through (4) and other relevant matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Oct. 19, 2021>
 Article 23 (Safety Control of High-Risk Pathogens)
(1) A person who intends to examine, possess, control, or transfer high-risk pathogens shall establish and operate facilities necessary for the examination, possession, control, and transfer thereof (hereinafter referred to as the "facilities handling high-risk pathogens"), or enter into a contract for the use of the facilities handling high-risk pathogens with a person who establishes and operates the facility handling high-risk pathogens. <Amended on Oct. 19, 2021>
(2) A person who intends to establish and operate facilities handling high-risk pathogens shall obtain permission from the Commissioner of the Korea Disease Control and Prevention Agency or file a report thereon with the Commissioner of the Korea Disease Control and Prevention Agency according to the safety control level of the facilities handling high-risk pathogens. In such cases, if there are two or more persons who intend to establish and operate the facilities handling high-risk pathogens, they shall obtain permission or file a report jointly. <Amended on Aug. 11, 2020; Oct. 19, 2021>
(3) Where a person who has obtained permission pursuant to paragraph (2) intends to modify any of the matters permitted, he or she shall obtain permission for such modification: Provided, That where he or she intends to modify any minor matter prescribed by Presidential Decree, he or she shall file a report on such modification.
(4) Where a person who has filed a report pursuant to paragraph (2) intends to modify any of the matters reported, he or she shall file a report on such modification.
(5) Where a person who has obtained permission or filed a report pursuant to paragraph (2) closes any facility handling high-risk pathogens, he or she shall file a report thereon with the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Aug. 11, 2020>
(6) Upon receipt of any report prescribed in paragraphs (2), (4), and (5), the Commissioner of the Korea Disease Control and Prevention Agency shall review the details of the report, and accept it if it is in compliance with this Act. <Amended on Aug. 11, 2020>
(7) A person who has obtained permission or filed a report pursuant to paragraph (2) shall comply with the safety control guidelines prescribed by Presidential Decree according to the safety control levels of facilities handling high-risk pathogens.
(8) The Commissioner of the Korea Disease Control and Prevention Agency may inspect whether a person who examines, possesses, controls, and transfers high-risk pathogens complies with the safety control guidelines referred to in paragraph (7), the standards for permission and reporting referred to in paragraph (9), etc. <Amended on Aug. 11, 2020>
(9) Matters necessary for the safety control levels of facilities handling high-risk pathogens, the standards and procedures for permission for and reporting on establishment and operation thereof, the standards and procedures for reporting on closure, etc. under paragraphs (1) through (5) shall be prescribed by Presidential Decree.
[This Article Wholly Amended on Mar. 4, 2020]
 Article 23-2 (Revocation of Permission for Facilities Handling High-Risk Pathogens)
Where a person who has obtained permission for or filed a report on establishment and operation of a facility handling high-risk pathogens pursuant to Article 23 (2) falls under any of the following subparagraphs, the Commissioner of the Korea Disease Control and Prevention Agency may revoke such permission or order the closure or suspension of operation of the facility handling high-risk pathogens for a specified period not exceeding one year: Provided, That in cases falling under subparagraph 1, the Commissioner of the Korea Disease Control and Prevention Agency shall revoke the permission or order the closure of the facility handling high-risk pathogens: <Amended on Mar. 4, 2020; Aug. 11, 2020; Oct. 19, 2021>
1. Where he or she has obtained the permission or filed the report by fraud or other improper means;
2. Where he or she modifies any of the matters permitted or reported without obtaining permission therefor or without filing a report thereon under Article 23 (3) or (4);
3. Where he or she fails to observe the safety control guidelines under Article 23 (7);
4. Where he or she fails to meet the standards for permission or reporting under Article 23 (9).
(2) A person whose permission is revoked under paragraph (1) or who is ordered to close the facilities handling high-risk pathogens shall destroy the high-risk pathogens in possession within 90 days and report the results thereof to the Commissioner of the Korea Disease Control and Prevention Agency: Provided, That where a person who is required to destroy high-risk pathogens and report thereon pursuant to the main clause files a request for an extension of the due date because it is impossible to process them by the date due to an act of God or any other unavoidable reason, the Commissioner of the Korea Disease Control and Prevention Agency may extend the due date by up to 90 days. <Added on Oct. 19, 2021>
(3) If a person whose permission is revoked pursuant to paragraph (1) or who is ordered to close the facilities handling high-risk pathogens fails to destroy the high-risk pathogens in possession and to report on the results of destruction by the due date specified in paragraph (2), the Commissioner of the Korea Disease Control and Prevention Agency may destroy the relevant high-risk pathogens. <Added on Oct. 19, 2021>
(4) Matters necessary for the methods and procedures for destroying high-risk pathogens under paragraphs (2) and (3) shall be prescribed by Ministerial Decree of Health and Welfare. <Added on Oct. 19, 2021>
[This Article Added on Dec. 12, 2017]
 Article 23-3 (Permission for Possessing Infectious Pathogens Spread through Bioterrorism)
(1) A person intending to possess any pathogen prescribed by Ministerial Decree of Health and Welfare (hereinafter referred to as "infectious pathogens spread through bioterrorism"), among the pathogens causing an infectious disease spread through bioterrorism, for the purposes of diagnosis, academic research, etc. of infectious diseases, shall obtain permission therefor from the Commissioner of the Korea Disease Control and Prevention Agency in advance: Provided, That where it is impracticable to obtain permission in advance due to unavoidable cause prescribed by Presidential Decree, including cases of possessing an infectious pathogens spread through bioterrorism after extracting it from a probable patient of an infectious disease, permission shall be obtained immediately after possessing such pathogen. <Amended on Aug. 11, 2020>
(2) A person who obtains permission for introducing high-risk pathogens into the domestic environment under Article 22 (1) shall be deemed to have obtained permission prescribed in paragraph (1).
(3) Any person intending to modify any of the matters permitted under paragraph (1) shall obtain permission for modification from the Commissioner of the Korea Disease Control and Prevention Agency: Provided, That in cases of modifying any minor matter prescribed by Presidential Decree, such as replacing a person handling high-risk pathogens, a report on such modification shall be submitted to the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Aug. 11, 2020>
(4) If a person who obtains permission for possession of infectious pathogens spread through bioterrorism pursuant to paragraph (1) obtains the permission by fraud or other improper means, the Commissioner of the Korea Disease Control and Prevention Agency shall revoke such permission. <Added on Oct. 19, 2021>
(5) Matters necessary for the methods and procedures for obtaining permission, permission for modification, reporting on modification, or revocation of permission under paragraphs (1) through (4), and other relevant matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Oct. 19, 2021>
[This Article Added on Dec. 3, 2019]
 Article 23-4 (Standards for Handling High-Risk Pathogens)
(1) High-risk pathogens can only be handled by any of the following persons:
1. A person who has graduated from a university or college of a level at least equivalent to a junior college referred to in subparagraph 4 of Article 2 of the Higher Education Act, majoring in a field related to health and medical services or biology, or a person having an academic background equivalent thereto;
2. A person who has at least two years of working experience in a field related to health and medical services or biology, among those who have graduated from a university or college of a level at least equivalent to a junior college referred to in subparagraph 4 of Article 2 of the Higher Education Act or who have an academic background at least equivalent thereto, majoring in a field other than health and medical services or biology;
3. A person who has at least four years of working experience in a field related to health and medical services or biology, among those who have graduated from a high school or high technical school referred to in subparagraph 3 of Article 2 of the Elementary and Secondary Education Act or who have an academic background at least equivalent thereto.
(2) No one shall permit any person not falling under any subparagraph of paragraph (1) to handle high-risk pathogens.
(3) Detailed matters for the academic background and working experience prescribed in the subparagraphs of paragraph (1) shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Dec. 3, 2019]
 Article 23-5 (Education on Handling High-Risk Pathogens)
(1) A person who handles high-risk pathogens shall receive necessary education for the safe handling of high-risk pathogens each year.
(2) The Commissioner of the Korea Disease Control and Prevention Agency may entrust the conduct of education prescribed in paragraph (1) to a specialized institution or organization prescribed by Ministerial Decree of Health and Welfare. <Amended on Aug. 11, 2020>
(3) Matters necessary for education and the entrustment thereof prescribed in paragraphs (1) and (2) shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Dec. 3, 2019]
CHAPTER VI VACCINATION
 Article 24 (Mandatory Vaccination)
(1) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall provide mandatory vaccination services (hereinafter referred to as "mandatory vaccination") at public health centers under his or her jurisdiction for the following: <Amended on Jan. 18, 2010; Mar. 22, 2013; Mar. 18, 2014; Dec. 2, 2016; Mar. 27, 2018; Aug. 11, 2020; Mar. 28, 2023; Jun. 13, 2023>
1. Diphtheria;
2. Poliomyelitis;
3. Pertussis;
4. Measles;
5. Tetanus;
6. Tuberculosis;
7. Hepatitis B;
8. Mumps;
9. Rubella;
10. Varicella;
11. Japanese encephalitis;
12. Haemophilus influenzae type B;
13. Pneumococcus;
14. Influenza;
15. Hepatitis A;
16. Human papilloma virus infection;
17. Group A rotavirus gastroenteritis;
18. Other infectious diseases designated by the Commissioner of the Korea Disease Control and Prevention Agency as deemed necessary for preventing infectious diseases.
(2) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may entrust medical institutions prescribed in the Medical Service Act within his or her jurisdiction with the affairs of mandatory vaccination under paragraph (1), as prescribed by Presidential Decree. <Amended on Mar. 27, 2018; Jun 13, 2023>
(3) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall give a prior notice to the parents of children subject to mandatory vaccination (including legal representatives of children), of such mandatory vaccination, as prescribed by Ministerial Decree of Health and Welfare. In such cases, he or she may process personally identifiable information referred to in Article 24 of the Personal Information Protection Act. <Added on May 23, 2012; Mar. 27, 2018; Jun. 13, 2023; Jan. 23, 2024>
[Title Amended on Mar. 27, 2018]
 Article 25 (Special Vaccination)
(1) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall provide special vaccination services (hereinafter referred to as "special vaccination") at public health centers under his or her jurisdiction in any of the following cases: <Amended on Jan. 18, 2010; Aug. 11, 2020; Jun. 13, 2023>
1. Where the Commissioner of the Korea Disease Control and Prevention Agency requests a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu to provide vaccination services for preventing infectious diseases;
2. Where a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu deems vaccinations necessary for preventing infectious diseases.
(2) Article 24 (2) shall apply mutatis mutandis to the entrustment of special vaccination specified in paragraph (1).
 Article 26 (Public Announcement of Vaccination)
Where a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu is to provide special vaccination services, he or she shall determine the date, time, place, type of vaccination, and scope of persons subject to vaccination, and shall make prior public announcement thereof on the website: Provided, That in cases of any changes in the standards, etc. for providing vaccination services under Article 32 (3), prior public announcement of such changes shall be made on the website. <Amended on Mar. 9, 2021; Jun. 13, 2023>
 Article 26-2 (Pre-Checking of Vaccination Records)
(1) The director of each public health center and the head of each medical institution entrusted with vaccination services under Article 24 (2) (including where the same is applied mutatis mutandis in Article 25 (2)), before providing vaccination services, shall check on the vaccination record of a person who intends to be vaccinated, with consent from the relevant person him or herself or his or her legal representative, as prescribed by Presidential Decree: Provided, That this shall not apply where consent is not obtained from such person or his or her legal representative.
(2) The pre-checking of a vaccination record referred to in the main clause of paragraph (1) may be made through the integrated vaccination management system specified in Article 33-4. <Amended on Dec. 3, 2019>
[This Article Added on Dec. 29, 2015]
 Article 27 (Certificates of Vaccination)
(1) The Commissioner of the Korea Disease Control and Prevention Agency, a Special Self-Governing City Mayor, a Special Self-Governing Province Governor, or the head of a Si/Gun/Gu shall issue a certificate of vaccination to those who have undergone mandatory vaccination or special vaccination or their legal representatives, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Dec. 29, 2015; Mar. 27, 2018; Aug. 11, 2020; Jun. 13, 2023>
(2) Where a person, other than a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, provides vaccination services under this Act, the Commissioner of the Korea Disease Control and Prevention Agency, the Special Self-Governing City Mayor, the Special Self-Governing Province Governor, or the head of the Si/Gun/Gu may authorize the person who has provided vaccination services to issue a certificate of vaccination, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Dec. 29, 2015; Aug. 11, 2020; Jun. 13, 2023>
(3) Certificates of vaccination referred to in paragraphs (1) and (2) may be issued in electronic form.
 Article 28 (Keeping and Reporting of Vaccination Records)
(1) Where a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu provides mandatory or special vaccination, or receives a report under paragraph (2), he or she shall prepare and keep records on vaccinations, as prescribed by Ministerial Decree of Health and Welfare; and the Special Self-Governing City Mayor, or the Special Self-Governing Province Governor shall report the details thereof to the Commissioner of the Korea Disease Control and Prevention Agency, and the head of the Si/Gun/Gu to the competent Mayor/Do Governor, respectively. <Amended on Jan. 18, 2010; Mar. 27, 2018; Aug. 11, 2020; Jun. 13, 2023>
(2) Where a person, other than a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, provides vaccination services under this Act, he or she shall report to the Special Self-Governing City Mayor, the Special Self-Governing Province Governor or the head of the competent Si/Gun/Gu, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jun. 13, 2023>
 Article 29 (Epidemiological Investigations on Vaccination)
The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor or the head of a Si/Gun/Gu shall conduct an investigation, based on the following classifications, and if any case of an adverse reaction to vaccinations occurs, he or she shall conduct an epidemiological investigation pursuant to Article 18 to establish its cause: <Amended on Aug. 11, 2020>
1. The Commissioner of the Korea Disease Control and Prevention Agency: An investigation into the effects of vaccinations, and adverse reactions to vaccinations;
2. A Mayor/Do Governor or the head of a Si/Gun/Gu: An investigation into adverse reactions to vaccinations.
 Article 29-2 (Testing of Adverse Reactions to Vaccination)
(1) If a medical personnel or the head of a medical institution under the Medical Service Act discovers any person who has shown or is suspected of having adverse reactions prescribed by Ministerial Decree of Health and Welfare, such as thrombosis with thrombocytopenia syndrome, after mandatory vaccination or temporary vaccination, he or she may request the Commissioner of the Korea Disease Control and Prevention Agency to conduct tests on adverse reactions.
(2) The Commissioner of the Korea Disease Control and Prevention Agency in receipt of a request under paragraph (1) shall conduct tests.
(3) The items to be inspected, the methods and procedures for requesting inspections, and the methods of inspections under paragraphs (1) and (2) shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency.
[This Article Added on Sep. 14, 2023]
 Article 30 (Vaccination Injury Investigation Teams)
(1) A vaccination injury investigation team shall be established under the Korea Disease Control and Prevention Agency to investigate the causes of diseases, disabilities, and death resulting from vaccinations referred to in Article 71 (1) and (2), and compensation, etc. for injury therefrom, and to investigate a third party's intention or negligence under Article 72 (1). <Amended on Aug. 11, 2020>
(2) Matters necessary for the establishment, operation, etc. of a vaccination injury investigation team prescribed in paragraph (1) shall be prescribed by Presidential Decree.
 Article 31 (Ascertainment as to Completion of Vaccination)
(1) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may request the principal of an elementary school and the principal of a middle school to submit inspection records on whether vaccination has been completed under Article 10 of the School Health Act. <Amended on Jun. 13, 2023>
(2) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may request the head of a kindergarten defined under the Early Childhood Education Act and the head of a day care center defined under the Child Care Act to ascertain whether infants and young children have been vaccinated, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jun. 7, 2011; Jun. 13, 2023>
(3) If a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu finds that some infants, young children, students, etc. have not been vaccinated after verifying records submitted under paragraph (1) and results of ascertainment under paragraph (2), he or she shall vaccinate such infants, young children, students, etc. <Amended on Jun. 13, 2023>
 Article 32 (Vaccination Week and Standards for Vaccination)
(1) The Commissioner of the Korea Disease Control and Prevention Agency may promulgate Vaccination Week to promote vaccination against infectious diseases by raising citizens' interest to get vaccinated. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(2) No person shall be vaccinated by fraud or other improper means. <Added on Mar. 9, 2021>
(3) Matters necessary for standards for and methods of conducting vaccination and other relevant matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 9, 2021>
 Article 32-2 (Vaccination Leave)
(1) An employer may grant paid leave to an employee who has been vaccinated under this Act. In such cases, the State and a local government may, if necessary, subsidize the employer for the expenses incurred in such paid leave.
(2) Where a person prescribed by Presidential Decree, such as an insured person under subparagraph 1 of Article 2 of the Employment Insurance Act, cannot take paid leave under paragraph (1), the State and a local government may subsidize for the expenses incurred therein.
(3) Matters necessary for vaccination and the scope of subsidization under paragraphs (1) and (2), application and subsidization procedures, etc. shall be prescribed by Presidential Decree.
[This Article Added on May 19, 2023]
 Article 33 (Planned Production of Vaccines)
(1) Where the Commissioner of the Korea Disease Control and Prevention Agency determines that the domestic supply of vaccines is insufficient or in other cases prescribed by Ministerial Decree of Health and Welfare, he or she may pre-compute the number of vaccines necessary for vaccination against infectious diseases and require a medicine manufacturer under Article 31 of the Pharmaceutical Affairs Act (hereinafter referred to as "medicine manufacturer") to produce them, and subsidize researchers, etc. of vaccines within the budget. <Amended on Jan. 18, 2010; Dec. 3, 2019; Aug. 11, 2020>
(2) The Commissioner of the Korea Disease Control and Prevention Agency may fully or partially prepay expenses incurred in producing vaccines under paragraph (1) to the relevant medicine manufacturer, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Aug. 11, 2020>
 Article 33-2 (Stockpiling Mandatory Vaccines)
(1) In order to facilitate mandatory vaccination services referred to in Article 24 and special vaccination services referred to in Article 25, the Commissioner of the Korea Disease Control and Prevention Agency may take preemptive measures for stockpiling necessary mandatory vaccines, etc. or concluding a contract for long-term purchases thereof, after undergoing deliberation by the Committee. <Amended on Aug. 11, 2020>
(2) The Commissioner of the Korea Disease Control and Prevention Agency may determine the distribution criteria, such as the priority of supplying mandatory vaccines, etc. stockpiled pursuant to paragraph (1), and other necessary matters, after undergoing deliberation by the Committee. <Amended on Aug. 11, 2020>
[This Article Added on Dec. 3, 2019]
[Previous Article 33-2 moved to Article 33-4 <Dec. 3, 2019>]
 Article 33-3 (Reporting Plans for Producing Mandatory Vaccines)
A person intending to produce or import mandatory vaccines, etc., from among those who have obtained permission or filed a notification by item pursuant to Article 31 or 42 of the Pharmaceutical Affairs Act, shall submit a plan for producing or importing mandatory vaccines, etc. (including any modification thereof) and the implementation results thereof to the Commissioner of the Korea Disease Control and Prevention Agency, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Aug. 11, 2020>
[This Article Added on Dec. 3, 2019]
 Article 33-4 (Establishment and Operation of Integrated Vaccination Management System)
(1) To efficiently process various data or information required for providing vaccination services and computerize the recording and management affairs, the Commissioner of the Korea Disease Control and Prevention Agency shall establish and operate an integrated vaccination management system (hereinafter referred to as the "Integrated Management System"). <Amended on Aug. 11, 2020>
(2) The Commissioner of the Korea Disease Control and Prevention Agency may collect, manage, and maintain the following data for establishing and operating the Integrated Management System, and request related agencies and organizations to provide necessary data. In such cases, the agencies and organizations in receipt of such request shall comply therewith unless there is good cause: <Amended on Aug. 11, 2020; Mar. 28, 2023>
1. Personal information of persons who should be vaccinated (including personally identifiable information referred to in Article 24 of the Personal Information Protection Act and other personal information prescribed in Presidential Decree);
2. Details of vaccinations, including the names of persons vaccinated, vaccine names, and dates of vaccinations;
3. Other data prescribed by Presidential Decree as necessary for vaccination services, including information on the opening of medical institutions entrusted with vaccination services, details of reporting on adverse reactions to vaccinations under Articles 11 and 13, details of epidemiological investigations on vaccination under Article 29, details of applications for compensation for injuries caused by vaccination under Article 71.
(3) The director of each public health center and the head of each medical institution entrusted with vaccination services under Article 24 (2) (including where the same is applied mutatis mutandis in Article 25 (2)), after providing vaccination services under this Act, shall enter information specified in paragraph (2) 2 in the Integrated Management System, as prescribed by Presidential Decree.
(4) The Commissioner of the Korea Disease Control and Prevention Agency may provide the parents of children who should be vaccinated with the details of vaccinations of their children or may support the issuance of certificates of vaccination, by utilizing the Integrated Management System, as prescribed by Presidential Decree. In such cases, to verify suitability for providing the details of vaccinations or issuing a certificate of vaccination, he or she may request the Minister of National Court Administration to furnish computerized registration data referred to in Article 11 of the Act on the Registration of Family Relations; and the Minister of National Court Administration shall comply therewith unless there is good cause. <Amended on Aug. 11, 2020>
(5) The Integrated Management System may be utilized through electronic linkage with the following information systems related to vaccination services: <Amended on Jan. 11, 2022>
1. The education information system referred to in Article 30-4 of the Elementary and Secondary Education Act;
2. The early childhood education information system referred to in Article 19-2 of the Early Childhood Education Act;
3. Other information systems prescribed by Ministerial Decree of Health and Welfare, including the integrated electronic civil petition window referred to in Article 12-2 (3) of the Civil Petitions Treatment Act.
(6) Except as provided in this Act, matters concerning the protection and management of information referred to in paragraphs (1) through (5) shall be governed by the Personal Information Protection Act.
[This Article Added on Dec. 29, 2015]
[Moved from Article 33-2 <Dec. 3, 2019>]
CHAPTER VII MEASURES TO PREVENT SPREAD OF INFECTIOUS DISEASES
 Article 34 (Formulation and Implementation of Crisis Control Measures against Infectious Diseases)
(1) The Commissioner of the Korea Disease Control and Prevention Agency shall formulate and implement crisis control measures against infectious diseases (hereinafter referred to as "crisis control measures against infectious diseases") after deliberation by the Committee in order to respond to an emergency resulting from the spread of infectious diseases or the transmission of new overseas infectious diseases into the Republic of Korea. <Amended on Jan. 18, 2010; Jul. 6, 2015; Aug. 11, 2020>
(2) Crisis control measures against infectious diseases shall include the following: <Amended on Jan. 18, 2010; Jul. 6, 2015; Aug. 11, 2020; Sep. 29, 2020; Dec. 15, 2020; Mar. 9, 2021; Sep. 14, 2023>
1. Systems for responding to the occurrence of a disaster and the transmission of overseas emerging infectious diseases, and roles therein by agency;
2. Judgment on a disaster or emergency, decision on emergency warning, and disaster and emergency management systems;
3. Preparation of the lists of experts, such as medical personnel, facilities, and medical institutions to be mobilized during an infectious disease emergency;
4. Schemes for stockpiling and procuring medical and quarantine supplies;
5. Training for actual situations, such as citizens' codes of conduct and education and map exercise for the personnel, facilities, and institutions to be mobilized, by a disaster or emergency, and crisis response to infectious diseases requiring urgent response, such as Class 1 infectious diseases;
5-2. Response measures for persons vulnerable to infection and social welfare facilities by type, based on the status of the outbreak and transmission of infectious diseases;
6. Other matters deemed necessary by the Commissioner of the Korea Disease Control and Prevention Agency for copying with disasters or emergencies.
(3) The Commissioner of the Korea Disease Control and Prevention Agency shall regularly conduct training, based on crisis control measures against infectious diseases. <Added on Jul. 6, 2015; Aug. 11, 2020>
(4) Matters necessary for the formulation, implementation, etc. of crisis control measures against infectious diseases shall be prescribed by Presidential Decree. <Amended on Jul. 6, 2015>
 Article 34-2 (Disclosure of Information during Infectious Disease Emergency)
(1) Where the spread of an infectious disease harmful to citizens' health triggers the issuance of a crisis alert of the caution level or higher prescribed in Article 38 (2) of the Framework Act on the Management of Disasters and Safety, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, and the head of a Si/Gun/Gu shall promptly disclose information that citizens need to know to prevent the infectious disease, such as the movement paths, transportation means, medical treatment institutions, and contacts of patients of the infectious disease, the current status of the outbreak and testing of the disease infectious by region and by age group, using such means as posting the information on information and communications networks and distributing a press release: Provided, That gender, age, and other information prescribed by Presidential Decree, which is deemed irrelevant to the prevention of the infectious disease, shall be excluded. <Amended on Mar. 4, 2020; Aug. 11, 2020; Sep. 29, 2020; Mar. 9, 2021>
(2) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall delete the information disclosed pursuant to paragraph (1) without delay if it is no longer necessary to disclose such information due to the achievement of the purpose of disclosure, etc. <Added on Sep. 29, 2020>
(3) Where any information disclosed under paragraph (1) falls under any of the following subparagraphs, the relevant person may file an objection with the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu in writing, orally, or using information and communications networks: <Added on Mar. 4, 2020; Aug. 11, 2020; Sep. 29, 2020>
1. Where any disclosed information is different from the actual fact;
2. Where he or she has any opinion on any disclosed information.
(4) Where the Commissioner of the Korea Disease Control and Prevention Agency deems that the objection raised under paragraph (3) is well-grounded, he or she shall without delay take necessary measures, such as correcting the relevant disclosed information. <Added on Mar. 4, 2020; Aug. 11, 2020; Sep. 29, 2020>
(5) Matters necessary for disclosing and deleting information and the scope of, procedures, methods, etc. for raising objections under paragraphs (1) through (3) shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Mar. 4, 2020; Sep. 29, 2020>
[This Article Added on Jul. 6, 2015]
 Article 35 (Formulation of Crisis Control Measures against Infectious Diseases by City/Do)
(1) The Commissioner of the Korea Disease Control and Prevention Agency shall notify Mayors/Do Governors of crisis control measures against infectious diseases formulated under Article 34 (1). <Amended on Jan. 18, 2010; Aug. 11, 2020>
(2) Each Mayor/Do Governor shall formulate and implement crisis control measures against infectious diseases by each Special Metropolitan City, Metropolitan City, Special Self-Governing City, Do, or Special Self-Governing Province (hereinafter referred to as "City/Do"), based on the crisis control measures against infectious diseases notified under paragraph (1). <Amended on Jun. 13, 2023>
 Article 35-2 (Prohibition of Presentation of False Statement to Medical Personnel during Disaster)
No one shall make a false statement, present false materials, or intentionally omit or conceal any fact to medical personnel with respect to facts necessary for confirming whether the relevant party is infected, including records of visits to medical institutions and of medical treatment, after a forecast or alert is issued to indicate the level of caution or higher under Article 38 (2) of the Framework Act on the Management of Disasters and Safety. <Amended on Dec. 12, 2017>
[This Article Added on Jul. 6, 2015]
 Article 36 (Designation of Infectious Disease Control Institutions)
(1) The Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor shall designate a medical institution referred to in Article 3 of the Medical Service Act as an infectious disease control institution, as prescribed by Ministerial Decree of Health and Welfare. <Added on Mar. 4, 2020; Aug. 11, 2020>
(2) The head of a Si/Gun/Gu may designate a medical institution prescribed in the Medical Service Act as an infectious disease control institution, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 4, 2020>
(3) The head of a medical institution designated under paragraphs (1) and (2) (hereinafter referred to as "infectious disease control institution") shall establish facilities for preventing infectious diseases and for treating patients of an infectious disease, etc. (hereinafter referred to as "infectious disease control facilities"). In such cases, an infectious disease control institution that exceeds the scale prescribed by Ministerial Decree of Health and Welfare, shall establish single-occupancy hospital rooms with anterooms, negative pressure facilities, etc. in accordance with the standards prescribed by Ministerial Decree of Health and Welfare, in order to prevent the spread of an infectious disease. <Amended on Jan. 18, 2010; Dec. 29, 2015; Mar. 4, 2020>
(4) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor or the head of a Si/Gun/Gu shall subsidize expenses incurred in establishing and operating infectious disease control facilities to infectious disease control institutions. <Amended on Mar. 4, 2020; Aug. 11, 2020>
(5) Where a medical institution, other than an infectious disease control institution, intends to establish and operate infectious disease control facilities, it shall report such fact to a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, as prescribed by Ministerial Decree of Health and Welfare. In such cases, the Special Self-Governing City Mayor, the Special Self-Governing Province Governor or the head of the relevant Si/Gun/Gu shall review the details of such report, and accept it if it is in compliance with this Act. <Amended on Jan. 18, 2010; Mar. 4, 2020; Jun. 13, 2023>
(6) When an emergency occurs, including the outbreak of an infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may instruct infectious disease control institutions to conduct any necessary affairs, such as commencing medical treatment. <Added on Jul. 6, 2015; Mar. 4, 2020; Aug. 11, 2020>
 Article 37 (Establishment of Infectious Disease Control Institutions during Infectious Disease Emergencies)
(1) Where patients of an infectious disease occur in mass or infectious disease control institutions designated under Article 36 are insufficient to accommodate all patients of an infectious disease, etc., the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may take the following measures: <Amended on Jan. 18, 2010; Aug. 11, 2020>
1. Designating any medical institution, other than infectious disease control institutions designated under Article 36, as an infectious disease control institution for a certain period;
2. Establishing and operating isolation wards, sanatoriums, or clinics.
(2) The head of an infectious disease control institution designated under paragraph (1) 1 shall establish infectious disease control facilities, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
(3) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall subsidize expenses incurred in establishing and operating facilities under paragraph (2), to infectious disease control institutions. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(4) No head of an infectious disease control institution designated under paragraph (1) 1 may refuse any order issued under paragraph (2) without good cause.
(5) When an emergency occurs, including the outbreak of an infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may order infectious disease control institutions to conduct any necessary affairs, such as the beginning of medical treatment. <Added on Jul. 6, 2015; Mar. 27, 2018; Aug. 11, 2020>
 Article 38 (Prohibition of Refusal to Hospitalize Patients of Infectious Disease)
No infectious disease control institution may refuse to hospitalize patients of an infectious disease, etc. without good cause.
 Article 39 (Methods of Establishing and Managing Infectious Disease Control Facilities)
Matters necessary for methods, etc. of establishing and operating infectious disease control institutions, and isolation wards, sanatoriums, or clinics under Article 37 shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 39-2 (Evaluation of Infectious Disease Control Facilities)
The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may conduct evaluations of infectious disease control institutions regularly, and reflect the findings thereof in the supervision, support, etc. of said institutions. In such cases, methods, process, and time-frame of such evaluations, details of the supervision and support, and other related matters, shall be determined by Ministerial Decree of Health and Welfare. <Amended on Aug. 11, 2020>
[This Article Added on Dec. 29, 2015]
 Article 39-3 (Designation of Facilities for Quarantining Persons Suspected of Contracting Infectious Disease)
(1) A Mayor/Do Governor shall designate a facility for quarantining persons suspected of contracting an infectious disease (hereinafter referred to as "facility for quarantining persons suspected of contracting an infectious disease") upon the outbreak or epidemic of such disease: Provided, That a medical institution under Article 3 of the Medical Service Act shall not be designated as a facility for quarantining persons suspected of contracting an infectious disease. <Amended on Dec. 15, 2020>
(2) Where persons suspected of contracting an infectious disease occur in mass or facilities for quarantining persons suspected of contracting an infectious disease designated under paragraph (1) are insufficient to accommodate all persons suspected of contracting an infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor may designate a facility, other than facilities for quarantining persons suspected of contracting an infectious disease designated under paragraph (1), as a facility for quarantining persons suspected of contracting an infectious disease for a certain period. <Amended on Aug. 11, 2020; Dec. 15, 2020>
(3) Matters necessary for methods for designating and managing facilities for quarantining persons suspected of contracting an infectious disease under paragraphs (1) and (2) and other matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Dec. 15, 2020>
[This Article Added on Mar. 27, 2018]
[Title Amended on Dec. 15, 2020]
 Article 40 (Stockpiling Medical and Quarantine Supplies in Preparation for Infectious Diseases Spread through Bioterrorism)
(1) When there is a likelihood of a pandemic of infectious diseases spread through bioterrorisms or any other infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency may determine preventive and therapeutic medical and quarantine supplies, subject to deliberation by the Committee, and stockpile them or enter an agreement in advance for their long-term purchase. <Amended on Jan. 18, 2010; Aug. 11, 2020; Dec. 15, 2020>
(2) When there is a likelihood of a pandemic of an infectious disease spread through bioterrorism and any other infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency may determine preventive and therapeutic medicines and require medicine manufacturers to produce them, notwithstanding Article 31 (2) of the Pharmaceutical Affairs Act. <Amended on Jan. 18, 2010; Dec. 3, 2019; Aug. 11, 2020>
(3) The Commissioner of the Korea Disease Control and Prevention Agency shall investigate the efficacy and adverse reactions of preventive and therapeutic medicines under paragraph (2), and conduct epidemiological investigations pursuant to Article 18 if any case of adverse reactions occurs. <Amended on Jan. 18, 2010; Aug. 11, 2020>
[Title Amended on Dec. 15, 2020]
 Article 40-2 (Distribution Standards including Priority in Supplying Medical and Quarantine Supplies for Infectious Diseases)
The Commissioner of the Korea Disease Control and Prevention Agency may determine distribution standards, including priorities in supplying medical and quarantine supplies (limited to drugs under the Pharmaceutical Affairs Act and medical devices under the Medical Devices Act) stockpiled or produced under Article 40 (1) and (2) in preparation for a pandemic of infectious diseases spread by biological terrorism or any other infectious disease, and other necessary matters, subject to deliberation by the Committee. In such cases, the Commissioner shall endeavor to establish the distribution standards to preferentially provide the medical and quarantine supplies to any of the following regions: <Amended on Aug. 11, 2020; Dec. 15, 2020; Jun. 10, 2022>
1. An area declared a special disaster area under Article 60 of the Framework Act on the Management of Disasters and Safety due to the spread of an infectious disease;
2. An area where an infectious disease is spreading, or is likely to spread, rapidly, which is prescribed by the Commissioner of the Korea Disease Control and Prevention Agency in consideration of the current status of the sickbeds, severity of patients' diseases, etc.
[This Article Added on Mar. 18, 2014]
[Title Amended on Jun. 10, 2022]
 Article 40-3 (Export Embargoes)
(1) Where any Class 1 infectious disease breaks out and the public health is likely to be harmed significantly due to a sudden price increase or lack of supply of products prescribed by Ministerial Decree of Health and Welfare, out of medical and quarantine supplies necessary for disease prevention, quarantine, and treatment, the Minister of Health and Welfare may prohibit the relevant products from being exported or shipped out of the Republic of Korea. <Amended on Dec. 15, 2020>
(2) Where the Minister of Health and Welfare intends to impose an embargo prescribed in paragraph (1), he or she shall have a prior consultation with the heads of the relevant central administrative agencies, and determine and publicize an embargo period in advance.
[This Article Added on Mar. 4, 2020]
 Article 40-4 (Stockpiling of Medical and Quarantine Supplies by Local Governments in Preparation for Infectious Diseases)
A Mayor/Do Governor or the head of a Si/Gun/Gu may take necessary measures such as stockpiling and managing medical and quarantine supplies in preparation for an infectious disease and disbursing them when a disaster occurs, to cope with the outbreak of an infectious disease or a disaster caused by an inflow of a new overseas infectious disease into the Republic of Korea. <Amended on Dec. 15, 2020>
[This Article Added on Sep. 29, 2020]
[Title Amended on Dec. 15, 2020]
 Article 40-5 (Integrated Infectious Disease Control Information System)
(1) To efficiently process various data or information necessary for preventing, controlling, and treating infectious diseases and computerizing the recording and management of such data or information, the Commissioner of the Korea Disease Control and Prevention Agency may establish and operate an integrated infectious disease control information system that manages patients, etc. of an infectious disease, medical personnel under the Medical Service Act, drugs, equipment, etc. (hereinafter referred to as "infectious disease information system").
(2) The Commissioner of the Korea Disease Control and Prevention Agency may collect, manage, retain, and process the following data for establishing and operating the infectious disease information system, and request related agencies and organizations to provide necessary data. In such cases, the agencies and organizations in receipt of such request shall comply therewith, unless there is good cause:
1. Personal information of patients of an infectious disease, etc. (including personally identifiable information defined in Article 24 of the Personal Information Protection Act and other personal information prescribed by Presidential Decree);
2. Details of treatment of infectious diseases and other data prescribed by Presidential Decree as necessary for preventing, managing, and treating patients of an infectious disease, etc.
(3) An infectious disease information system may be utilized by electronically linking it to the following information systems; in such cases, data or information that may be collected through such linkage shall be limited to those for the prevention, management and treatment of patients of an infectious disease, etc.: <Amended on Jan. 17, 2023; Aug. 16, 2023>
1. An information system that processes electronic information on resident registration under Article 28 (1) of the Resident Registration Act;
2. A regional healthcare information system provided in Article 5 (1) of the Regional Public Health Act;
3. The Integrated Food Safety Information Network provided in Article 24-2 of the Framework Act on Food Safety;
4. A national integrated information system for animal disease control provided in Article 3-3 of the Act on the Prevention of Contagious Animal Diseases;
5. An integrated system for disaster management resources under Article 46 of the Act on the Management of Disaster Management Resources;
6. Comprehensive tuberculosis control system under Article 7 (2) of the Tuberculosis Prevention Act;
7. Other information systems prescribed by Presidential Decree.
(4) Except as provided in this Act, matters concerning the protection and management of information referred to in paragraphs (1) through (3) shall be governed by the Personal Information Protection Act and the Official Information Disclosure Act.
(5) Matters necessary for the establishment and operation of an infectious disease information system, methods for requesting information related to infectious diseases, etc. shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Sep. 29, 2020]
 Article 40-6 (Special Cases concerning Purchase of Vaccines and Medicines in Development in Preparation for Infectious Diseases Spread through Bioterrorism)
(1) Where the Commissioner of the Korea Disease Control and Prevention Agency deems it difficult to address with existing vaccines or medicines against the pandemic of infectious diseases spread through bioterrorism and other infectious diseases, he or she may enter into a contract necessary for the purchase and supply of vaccines or medicines in development subject to deliberation by the Committee, notwithstanding the Act on Contracts to Which the State Is a Party.
(2) A public official shall not be subject to disciplinary action or reprimand or otherwise held liable under the State Public Officials Act or any other related statutes or regulations for the outcome of proactive performance of duties related to a contract or performance of a contract under paragraph (1), in the absence of intent or gross negligence on his or her part.
(3) The subject of and procedures for a contract under paragraph (1) and other necessary matters shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency in consultation with the Minister of Economy and Finance.
[This Article Added on Mar. 9, 2021]
 Article 41 (Control of Patients with Infectious Disease)
(1) Patients of an infectious disease, etc. with a particularly high risk of transmission, which falls under Class 1 infectious diseases or is an infectious disease publicly notified by the Commissioner of the Korea Disease Control and Prevention Agency, shall receive inpatient treatment at an infectious disease control institution, the Central Infectious Disease Hospital, a regional infectious disease hospital, or a medical institution with infectious disease control facilities (hereinafter referred to as "infectious disease control institution, etc."). <Amended on Jan. 18, 2010; Mar. 27, 2018; Aug. 11, 2020; Aug. 12, 2020; Aug. 16, 2023>
(2) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may allow any of the following persons to undergo self-care, treatment at facilities established and operated under Article 37 (1) 2 (hereinafter referred to as "facility treatment"), or inpatient treatment at medical institutions: <Amended on Jan. 18, 2010; Aug. 11, 2020; Aug. 12, 2020>
1. A person deemed by a medical doctor to be capable of undergoing self-care or facility treatment, notwithstanding paragraph (1);
2. A person who is not subject to inpatient treatment under paragraph (1);
3. A person suspected of contracting an infectious disease.
(3) In any of the following cases, the Minister of Health and Welfare, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor or the head of a Si/Gun/Gu may transfer persons undergoing treatment under paragraph (1) or (2) to other infectious disease control institutions or medical institutions which are not an infectious disease control institution, allow them to undergo self-care, or relocate them to facilities established and operated under Article 37 (1) 2 (hereinafter referred to as "transfer, etc."): <Added on Aug. 12, 2020; Sep. 29, 2020>
1. Where there is a change in severity;
2. Where the doctor deems that hospitalization is unnecessary;
3. Where the Commissioner of the Korea Disease Control and Prevention Agency deems that transfer, etc. is necessary due to shortage of isolation beds, etc.
(4) Patients, etc. with an infectious disease shall comply with the measures under paragraph (3), and where they refuse it without good cause, they shall bear expenses incurred in relation to medical treatment. <Added on Aug. 12, 2020>
(5) Matters necessary regarding methods and procedures of inpatient treatment, self-care, and facility treatment under paragraphs (1) and (2) and methods and procedures of transfer, etc. under paragraph (3) shall be prescribed by Presidential Decree. <Amended on Aug. 12, 2020>
 Article 41-2 (Employer’s Obligation to Cooperate)
(1) Where an employee is hospitalized, quarantined, or isolated under this Act, the relevant employer may grant a paid leave during the period of such hospitalization, quarantine, or isolation, in addition to the paid leave provided for in Article 60 of the Labor Standards Act. In such cases, if the cost of granting a paid leave is subsidized by the State, the employer shall provide the paid leave.
(2) No employer shall dismiss, or otherwise treat unfavorably, an employee on the reason of a paid leave granted under paragraph (1) and shall dismiss such employee during the period of the paid leave: Provided, That this shall not apply where the employer is unable to continue his or her business.
(3) The State may subsidize the cost of granting a paid leave under paragraph (1).
(4) The scope of subsidization granted under paragraph (3), procedures for application therefor, and other necessary matters, shall be prescribed by Presidential Decree.
[This Article Added on Dec. 29, 2015]
 Article 42 (Compulsory Dispositions with respect to Infectious Diseases)
(1) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may assign the relevant public official to conduct a necessary investigation or medical diagnosis by entering the residence, means of transportation, such as a ship, aircraft, or train, or any other place where a patient of any of the following infectious diseases, etc. is deemed present, and where such medical diagnosis deems that the relevant person is a patient of an infectious disease, etc., the relevant public official may escort and compel such person to undergo medical treatment or be hospitalized: <Amended on Jan. 18, 2010; Mar. 27, 2018; Aug. 11, 2020>
1. Class 1 infectious diseases;
2. Tuberculosis, measles, cholera, typhoid, paratyphoid, shigellosis, colon bacillus infection with enterorrhagia, hepatitis A, meningococcal meningitis, poliomyelitis, scarlet fever, and other infectious diseases determined by the Commissioner of the Korea Disease Control and Prevention Agency, among Class 2 infectious diseases;
3. Deleted; <Mar. 27, 2018>
4. Infectious diseases determined by the Commissioner of the Korea Disease Control and Prevention Agency, among Class 3 infectious diseases;
5. Infectious diseases under surveillance by the World Health Organization;
6. Deleted. <Mar. 27, 2018>
(2) Where any Class 1 infectious disease breaks out, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may have the relevant public official take the following measures for persons suspected of contracting the infectious disease. In such cases, the relevant public official may conduct a necessary investigation or medical diagnosis to confirm the presence or absence of infectious disease symptoms: <Added on Mar. 4, 2020; Aug. 11, 2020; Sep. 29, 2020>
1. Home quarantine or isolation, or institutional isolation;
1-2. Restriction on the means of transportation necessary for quarantine or isolation under subparagraph 1;
2. Ascertainment of the symptoms of an infectious disease or collection of location information, using wire or wireless communications, equipment utilizing information and communications technologies, etc. In such cases, the collection of location information shall be limited to persons quarantined or isolated under subparagraph 1;
3. Infection inspection.
(3) With respect to persons deemed patients of an infectious disease, etc. as a result of investigations or medical diagnosis referred to in paragraph (2), the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may assign the relevant public official to escort and compel such persons to undergo medical treatment or be hospitalized. <Added on Mar. 4, 2020; Aug. 11, 2020>
(4) Where a person refuses an investigation or medical diagnosis referred to in paragraphs (1) and (2) or a test referred to in Article 13 (2) (hereafter in this Article referred to as "investigation refuser"), the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall assign the relevant public official to escort such person to an infectious disease control institution and compel such person to undergo necessary investigation or diagnosis. <Amended on Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020>
(5) A public official who takes measures for investigation, medical diagnosis, quarantine or isolation, treatment, hospitalization, or escort pursuant to paragraphs (1) through (4) shall carry an identification indicating his or her authority and produce it to relevant persons. <Added on Dec. 29, 2015; Mar. 4, 2020>
(6) Where necessary for taking any measure for investigation, medical diagnosis, quarantine or isolation, treatment, or hospitalization prescribed in paragraphs (2) through (4) and (7), the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may request cooperation from the chief of the competent police station. In such cases, the chief of the competent police station in receipt of such request shall comply therewith unless there is a compelling reason not to do so. <Added on Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020>
(7) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may quarantine or isolate any investigation refuser at such refuser’s home or in an infectious disease control facility; and if the investigation refuser is deemed a patient of an infectious disease, etc. according to the results of an investigation or medical diagnosis conducted under paragraph (4), he or she shall compel such patient to undergo medical treatment or to be hospitalized in an infectious disease control facility. <Added on Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020>
(8) Where any person suspected of contracting an infectious disease or investigation refuser is found not to be a patient of an infectious disease, etc., the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall immediately release the investigator refuser from quarantine or isolation referred to in paragraph (2) or (7). <Added on Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020>
(9) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu gives medical treatment to, or hospitalizes, any investigation refuser pursuant to paragraph (7), he or she shall notify the guardian of the investigation refuser thereof. In such cases, Article 43 shall apply mutatis mutandis to matters necessary for the methods of, procedures, etc. for notification. <Added on Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020>
(10) Notwithstanding paragraph (8), if a disposition of quarantine or isolation is not released without good cause, the relevant persons suspected of contracting an infectious disease or investigation refuser may make a rescue claim seeking the release; and in regards to the process, methods, etc. of such rescue claim, the Habeas Corpus Act shall apply mutatis mutandis. In such cases, "person suspected of contracting an infectious disease or investigation refuser" shall be construed as "inmate"; and "Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/ Gu" who has ordered the disposition of quarantine or isolation shall be construed as "custodian" (for the purposes of this paragraph, the application of Article 6 (1) 3 of the Habeas Corpus Act shall be excluded). <Added on Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020>
(11) Matters necessary for the criteria for designating institutions to conduct investigations, medical diagnosis, quarantine or isolation, or treatment under paragraphs (1) through (4) and (7), the methods for quarantine and for checking the presence or absence of symptoms with regard to persons suspected of contracting an infectious disease under paragraph (2), and other relevant matters shall be prescribed by Presidential Decree. <Added on Dec. 29, 2015; Mar. 4, 2020>
(12) Matters concerning the storage, protection, use, and destruction of location information collected pursuant to paragraph (2) 2 shall be governed by the Act on the Protection and Use of Location Information. <Added on Sep. 29, 2020>
 Article 43 (Hospitalization Notice to Patients of Infectious Disease)
(1) Where a patient of an infectious disease, etc. needs to receive inpatient treatment under Article 41, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall notify the person subject to inpatient treatment and his or her guardian thereof. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(2) Matters necessary for methods of and procedures for notification under paragraph (1), and other relevant matters, shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 43-2 (Notification to Persons Subject to Quarantine or Isolation)
(1) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu takes any measure for hospitalization, quarantine, or isolation prescribed in Article 42 (2), (3), and (7), subparagraph 3 of Article 47, or Article 49 (1) 14, he or she shall notify such fact to persons subject to hospitalization, quarantine, or isolation and his or her guardian. <Amended on Aug. 11, 2020>
(2) Matters necessary for the methods of, procedures, etc. for notification referred to in paragraph (1) shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Mar. 4, 2020]
 Article 44 (Management of Imprisoned Patients)
The head of a correctional institution shall provide inmates infected with infectious diseases with measures to prevent the spread of the infectious disease and appropriate medical services.
 Article 45 (Temporary Restrictions on Work)
(1) No patients of an infectious disease, etc. may be engaged in any occupation involving frequent contact with the general public by its nature, and no one may hire patients of an infectious disease, etc. for such occupation, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
(2) If a person required to undergo a medical examination for a sexually transmitted infectious disease under Article 19 fails to undergo the medical examination, he or she shall not be engaged in any occupation provided for in that Article, and the person who operates the relevant business shall not permit any person who fails to undergo medical examination to be engaged in the business.
 Article 46 (Measures for Medical Examination and Vaccination)
The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may take measures for requiring any of the following persons to undergo a medical examination, or to receive a vaccination necessary for preventing an infectious disease, etc., as prescribed by Ministerial Decree of Health and Welfare: <Amended on Jan. 18, 2010; Jul. 6, 2015; Aug. 11, 2020>
1. Family members of a patient of an infectious disease, etc. or his or her cohabitants;
2. A person suspected of being infected by an infectious disease, who resides in or enters an area where the infectious disease breaks out;
3. A person suspected of being infected with an infectious disease through contact with patients of an infectious disease, etc.
 Article 47 (Control Measures against Epidemic of Infectious Diseases)
In order to prevent the further spread of an infectious disease upon the epidemic of the infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency, Mayors/Do Governors, or heads of Sis/Guns/Gus shall take all or some of the following measures: <Amended on Jul. 6, 2015; Mar. 4, 2020; Aug. 11, 2020>
1. The following measures for places where patients of an infectious disease, etc. are present or places deemed contaminated with the infectious pathogens:
(a) Temporary closure;
(b) Prohibition of entry of the general public;
(c) Restriction on movement into the relevant places;
(d) Other measures for passage blocking;
2. Suspending the business of a medical institution;
3. Hospitalizing or quarantining persons suspected of contracting an infectious disease at an appropriate place for a certain period.
4. Prohibiting the acts of using, receiving, moving, discarding, or cleaning things infected or suspected of being infected by the infectious pathogens, or burning up or disposing of such things;
5. Issuing an order to disinfect or take other necessary measures for, places infected by the infectious pathogens;
6. Issuing an order to prevent laundering at a specified place or to dispose of wastes at a specified place.
 Article 48 (Disinfection Measures for Infected Places)
(1) The commander of a unit belonging to the Army, Navy, or Air Force, the commander of a unit under direct control of the Ministry of National Defense, and a person falling under any subparagraph of Article 12 (1), shall disinfect or take other necessary measures for, places where patients of an infectious disease, etc. occurred, or places suspected of being contaminated with the infectious pathogens, in accordance with the direction of a physician, oriental medical doctor, or relevant public official.
(2) Matters necessary for taking measures, including disinfection, under paragraph (1), shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
CHAPTER VIII PREVENTIVE MEASURES
 Article 49 (Preventive Measures against Infectious Diseases)
(1) In order to prevent infectious diseases, the Commissioner of the Korea Disease Control and Prevention Agency, Mayors/Do Governors, or heads of Sis/Guns/Gus shall take all or some of the following measures; and the Minister of Health and Welfare may take measures under subparagraphs 2, 2-2 through 2-4, 12, and 12-2 to prevent infectious diseases: <Amended on Jul. 6, 2015; Dec. 29, 2015; Mar. 4, 2020; Aug. 11, 2020; Aug. 12, 2020; Sep. 29, 2020; Mar. 9, 2021>
1. Completely or partially holding up traffic in jurisdiction;
2. Restricting or prohibiting performances, assemblies, religious ceremonies, or any other large gathering of people;
2-2. Ordering the managers, operators, users, etc. of places or facilities with a risk of spreading an infectious disease to comply with the disease control guidelines, such as preparing a list of visitors and wearing a mask;
2-3. Ordering users of means of transport likely to transmit infectious diseases, such as buses, trains, ships, and aircraft to comply with disease control guidelines, such as wearing a mask;
2-4. Ordering the observance of disease control guidelines such as wearing a mask in a specific region during a specific period as infectious diseases are likely to spread;
3. Conducting medical examinations or performing autopsies or dissection of corpses;
4. Issuing an order to prohibit the sale or receipt of food that exposes the risk of transmitting infectious diseases, to discard such food, or to take other necessary disposal;
5. Issuing an order to take preventive measures for persons who have involved in slaughter for the prevention of zoonoses, or for persons, etc. exposed to zoonoses;
6. Issuing an order to restrict or prohibit the possession and transfer of things which may transmit infectious diseases, to destruct or incinerate such things, or to take other necessary disposal;
7. Issuing an order to assign physicians at any means of transportation, such as ships, aircraft, and trains, places of business, or other public places, or to install facilities necessary for the prevention of infectious diseases at such places;
8. Issuing an order to disinfect or take other necessary measures for, facilities or places related to public sanitation, or to prohibit the installation, remodeling, alteration, disuse, or use of waterworks, sewers, wells, garbage dumps, and lavatories;
9. Issuing an order to exterminate rodents, vermin, or other animals transmitting infectious diseases or to install facilities for exterminating such;
10. Restricting or prohibiting fishing or swimming at a specified place of water, or the use of a specified well;
11. Prohibiting capturing animals which are intermediate hosts transmitting infectious diseases, or prohibiting eating such animals in the raw state;
12. Mobilizing medical persons, medical practitioners, and other necessary medical personnel during an epidemic period of an infectious disease;
12-2. Mobilizing of facilities, such as sickbeds of medical institutions, training institutes, and accommodation facilities, during the epidemic period of an infectious disease;
13. Issuing an order to disinfect or take other necessary measures for places contaminated or likely to be contaminated with infectious pathogens;
14. Hospitalizing or quarantining persons suspected of contracting an infectious disease at an appropriate place for a certain period.
(2) Where a Mayor/Do Governor or the head of a Si/Gun/Gu intends to prohibit the use of drinking water pursuant to paragraph (1) 8 and 10, he or she shall separately supply drinking water during a period of such prohibition, and where a Mayor/Do Governor or the head of a Si/Gun/Gu intends to take measures under paragraph (1) 1, 2, 6, 8, 10, and 11, he or she shall preinform the relevant residents thereof.
(3) A Mayor/Do Governor or the head of a Si/Gun/Gu may order a manager or operator who fails to comply with the measures under paragraph (1) 2-2 to close the relevant place or facility, or to suspend operation within a prescribed period not exceeding three months: Provided, That where a person who has received an order to suspend operation continues to operate the relevant place or facility during the period of suspension of operation, he or she shall issue an order requiring closure of the relevant place or facility. <Added on Sep. 29, 2020; Mar. 9, 2021>
(4) A manager or operator in receipt of an order to close a place or facility or to suspend the operation thereof under paragraph (3) shall comply therewith unless there is good cause. <Added on Mar. 9, 2021>
(5) Where a manager or operator continues to operate a facility despite the closure order issued under paragraph (3), the Mayor/Do Governor or the head of the Si/Gun/Gu may require the relevant public official to take the following measures to close the relevant place or facility: <Added on Sep. 29, 2020; Mar. 9, 2021>
1. Removing the signboard or other signs of the relevant place or facility;
2. Posting a notice informing that the relevant place or facility is closed under paragraph (3).
(6) A Mayor/Do Governor or the head of a Si/Gun/Gu who has ordered the closing a place or facility pursuant to paragraph (3) may determine whether to suspend the closing of the relevant place or facility subject to deliberation by a local committee under Article 11 of the Framework Act on the Management of Disasters and Safety, if it is no longer necessary to close the relevant place or facility due to a change in crisis alert or guidelines for disease control. <Added on Mar. 9, 2021>
(5) Criteria for administrative dispositions referred to in paragraph (3) shall be prescribed by Ministerial Decree of Health and Welfare, taking into account the type, severity, etc. of the relevant violation. <Added on Sep. 29, 2020; Mar. 9, 2021>
 Article 49-2 (Protection Measures for Persons Vulnerable to Infection)
(1) Where a crisis alert of the caution level or higher prescribed in Article 38 (2) of the Framework Act on the Management of Disasters and Safety is issued, in order to protect low-income groups, and children, senior citizens, and persons with disabilities who use social welfare facilities, and other persons prescribed by Ministerial Decree of Health and Welfare (hereinafter referred to as "persons vulnerable to infection") from respiratory infectious diseases, the Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu may take necessary measures, such as disbursing medical and quarantine supplies (limited to quasi-drugs under the Pharmaceutical Affairs) to persons vulnerable to infection. <Amended on Dec. 15, 2020>
(2) Where a crisis alert of attention level or higher is issued under Article 38 (2) of the Framework Act on the Management of Disasters and Safety, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may order to take necessary measures such as disinfection of the social welfare facilities defined in subparagraph 4 of Article 2 of the Social Welfare Services Act that are used by persons vulnerable to infection. <Added on Mar. 9, 2021>
(2) Matters necessary for the types of infectious diseases, the scope of persons vulnerable to infection, the procedures for provision, and other relevant matters under paragraph (1) shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Mar. 9, 2021>
[This Article Added on Mar. 4, 2020]
 Article 49-3 (Temporary Non-Face-to-Face Diagnosis to Protect Medical Personnel, Patients, and Medical Institutions)
(1) When a crisis alert of a serious level or higher is issued under Article 38 (2) of the Framework Act on the Management of Disasters and Safety, notwithstanding Article 33 (1) of the Medical Service Act, medical personnel (limited to medical doctors, dentists, and oriental medical doctors among medical personnel defined in Article 2 of the Medical Service Act; hereafter in this Article, the same shall apply) engaged in medical service may continuously observe, diagnose, consult with, and prescribe medicines for, patients outside medical institutions with respect to their health and disease by using information and communications technologies such as wired, wireless, or image communications, and computers, within the scope determined by the Minister of Health and Welfare, where deemed necessary to protect patients, medical personnel, medical institutions, and others from the risk of infection.
(2) The Minister of Health and Welfare shall determine the scope, such as areas and period of temporary non-face-to-face diagnosis under paragraph (1), subject to deliberation by the Committee.
[This Article Added on Dec. 15, 2020]
 Article 50 (Other Preventive Measures against Infectious Diseases)
(1) Where patients of an infectious disease, etc. occur or are likely to occur, the commander of a unit belonging to the Army, Navy, or Air Force, the commander of a unit under direct control of the Ministry of National Defense, and a person falling under Article 12 (1) 2, shall take a disinfection measure or other necessary measures, and shall take additional measures necessary for preventing infectious diseases, consulting with a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu. <Amended on Jul. 6, 2015; Jun. 13, 2023>
(2) The Minister of Education or a superintendent of education shall consult with the Commissioner of the Korea Disease Control and Prevention Agency where he or she issues, on grounds of the outbreak of an infectious disease, an order for business suspension or temporary school closure prescribed in Article 64 of the Elementary and Secondary Education Act or an order for business suspension or temporary kindergarten closure prescribed in Article 31 of the Early Childhood Education Act, to schools defined in subparagraph 2 of Article 2 of the School Health Act. <Added on Jul. 6, 2015; Aug. 11, 2020>
 Article 51 (Disinfection Duty)
(1) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall conduct the cleaning or disinfection, and take measures to exterminate rodents, vermin, etc. (hereinafter referred to as "disinfection") in order to prevent infectious diseases. In such cases, disinfection shall be conducted safely by minimizing their harmful effects on human health and nature. <Amended on Jan. 18, 2010; Mar. 4, 2020; Jun. 13, 2023>
(2) The standards and methods for disinfection referred to in paragraph (1) shall be prescribed by Ministerial Decree of Health and Welfare. <Added on Mar. 4, 2020>
(3) A person who manages or operates facilities prescribed by Presidential Decree, among those resided or used by a multiple number of persons, such as multi-family housing and accommodations, shall conduct disinfection necessary for the prevention of infectious diseases, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 4, 2020>
(4) A facility manager or operator who is required to conduct disinfection under paragraph (3) shall authorize a person who has filed a report on his or her disinfection services pursuant to Article 52 (1) to conduct disinfection: Provided, That where a housing management service provider defined in Article 2 (1) 15 of the Multi-Family Housing Management Act is equipped with disinfection equipment stipulated in Article 52 (1), he or she may directly disinfect multi-family housing under his or her management. <Amended on Aug. 11, 2015; Mar. 4, 2020>
 Article 52 (Reporting on Business of Disinfection Services)
(1) A person who intends to provide disinfection services as business (excluding housing management service providers referred to in the proviso of Article 51 (4)) shall be equipped with facilities, equipment, and human resources prescribed by Ministerial Decree of Health and Welfare and file a reporting on disinfection services with a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu. The same shall also apply to the modification of matters already reported. <Amended on Jan. 18, 2010; Mar. 4, 2020; Jun. 13, 2023>
(2) Upon receiving a report referred to in paragraph (1), a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall review the details of the report, and accept it if it is in compliance with this Act. <Added on Mar. 4, 2020; Jun. 13, 2023>
(3) Where a person who has filed a report on disinfection services pursuant to paragraph (1) (hereinafter referred to as "disinfection service provider") falls under any of the following cases, a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall deem such report of disinfection services revoked: <Amended on Dec. 12, 2017; Dec. 31, 2018; Mar. 4, 2020; Dec. 22, 2020; Jun. 13, 2023>
1. Where he or she files a report on the closure of his or her business with the head of the competent tax office pursuant to Article 8 (8) of the Value-Added Tax Act;
2. Where the head of the competent tax office revokes the relevant business registration pursuant to Article 8 (9) of the Value-Added Tax Act;
3. Where facilities, etc. necessary for disinfection services have continued to be absent for at least six months without filing a report on suspension or closure of business under Article 53 (1).
(4) If necessary to deem a report on disinfection services revoked pursuant to paragraph (3), a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may request the head of the competent tax office to provide information about whether the disinfection service provider has closed his or her business. In such cases, the head of the competent tax office so requested shall provide information about whether the disinfection service provider has closed his or her business pursuant to Article 36 (1) of the Electronic Government Act. <Added on Dec. 12, 2017; Mar. 4, 2020; Jun. 13, 2023>
 Article 53 (Reporting on Suspension of Disinfection Services)
(1) Where a disinfection service provider intends to suspend his or her business for at least 30 days or to permanently close it, he or she shall file a report thereon with a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Mar. 4, 2020; Jun. 13, 2023>
(2) Where a disinfection service provider intends to reopen his or her business after suspending business, he or she shall file a report thereon with a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu, as prescribed by Ministerial Decree of Health and Welfare. In such cases, the Special Self-Governing City Mayor, the Special Self-Governing Province Governor or the head of the competent Si/Gun/Gu shall review the details of the report, and accept it if it is in compliance with this Act. <Added on Mar. 4, 2020; Jun. 13, 2023>
 Article 54 (Conducting Disinfections)
(1) A disinfection service provider shall conduct disinfection according to standards and methods determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
(2) Where a disinfection service provider has conducted disinfection, he or she shall record and keep matters concerning such disinfection, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 55 (Training for Disinfection Service Providers)
(1) A disinfection service provider (referring to a representative in cases of a corporation; hereafter the same shall apply in this Article) shall receive training on disinfection.
(2) A disinfection service provider shall ensure his or her employees engaged in disinfection services receive training in relation thereto.
(3) Matters necessary for the details and methods of training, hours of training, bearing of training expenses, etc. under paragraphs (1) and (2), shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 56 (Disinfection Service Agencies)
Where a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu is required to disinfect pursuant to subparagraph 5 of Article 47, Article 48 (1), Article 49 (1) 8, 9, and 13, Article 50, and Article 51 (1) and (3), he or she may authorize a disinfection service provider to disinfect on his or her behalf. <Amended on Jul. 6, 2015; Mar. 4, 2020; Jun. 13, 2023>
 Article 57 (Submission and Inspection of Documents)
(1) A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may assign a public official under his or her control to request disinfection service providers to submit relevant documents concerning rendering of disinfection services, or assign him or her to inspect such documents or ask questions to such disinfection service providers. <Amended on Jun. 13, 2023>
(2) A public official who requests disinfection service providers to submit documents, inspects such documents, or asks questions to disinfection service providers pursuant to paragraph (1), shall carry a certificate indicating his or her authority and produce it to interested parties.
 Article 58 (Corrective Orders)
Where a disinfection service provider falls under any of the following cases, a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu shall order him or her to correct the relevant violation within a specified period of at least one month: <Amended on Jun. 13, 2023>
1. Where he or she fails to satisfy requirements for facilities, equipment, and human resources under Article 52 (1);
2. Where he or she fails to receive training under Article 55 (1), or fails to have his or her employees engaging in disinfection services receive training under paragraph (2) of that Article.
 Article 59 (Suspension of Business)
(1) Where a disinfection service provider falls under any of the following cases, a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may order him or her to close his or her place of business, or to suspend business for a specified period of by up to six months: Provided, That in cases falling under subparagraph 5, an order to close his or her place of business shall be issued: <Amended on Mar. 4, 2020; Jun. 13, 2023>
1. Where he or she fails to file a report on modification prescribed in the latter part of Article 52 (1), or fails to file a report on the suspension, closure, or reopening of his or her business prescribed in Article 53 (1) and (2);
2. Where he or she conducts disinfection in disconformity with the standards and methods prescribed in Article 54 (1), or fails to record and retain matters concerning conducted disinfection, in violation of paragraph (2) of that Article;
3. Where he or she fails to comply with an order to submit relevant documents under Article 57, or refuses, obstructs, or evades inspections and questions by public officials in charge;
4. Where he or she fails to comply with corrective orders issued under Article 58;
5. Where he or she renders disinfection services during the suspension period of business.
(2) Where a disinfection service provider continues his or her business after he or she is ordered to close his or her place of business under paragraph (1), or renders disinfection services without filing a report required under Article 52 (1), a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may assign the relevant public officials to take the following measures in order to close the relevant place of business: <Amended on Jun. 13, 2023>
1. To remove or eliminate signboards of the relevant place of business, or any other business sign, etc.;
2. To display a sign, etc. indicating that the relevant place of business is illegitimate.
(3) Standards for administrative dispositions referred to in paragraph (1) shall be determined by Ministerial Decree of Health and Welfare, in consideration of the types, severity, etc. of relevant violations. <Amended on Jan. 18, 2010>
CHAPTER IX DISEASE CONTROL OFFICERS, EPIDEMIOLOGICAL INVESTIGATION OFFICERS, QUARANTINE INSPECTION COMMISSIONERS, AND DISEASE PREVENTION COMMISSIONERS
 Article 60 (Disease Control Officers)
(1) The Commissioner of the Korea Disease Control and Prevention Agency and each Mayor/Do Governor shall appoint disease control officers in charge of the affairs of infectious disease prevention and control, from among public officials of said Ministry or City/Do: Provided, That if necessary for dealing with the affairs of infectious disease prevention and control, the head of a Si/Gun/Gu may appoint disease control officers from among public officials of said Si/Gun/Gu. <Amended on Mar. 4, 2020; Aug. 11, 2020>
(2) Each disease control officer shall be in charge of affairs specified in Article 4 (2) 1 through 7: Provided, That each disease control officer of the Korea Disease Control and Prevention Agency shall also be in charge of affairs specified in Article 4 (2) 8. <Amended on Aug. 11, 2020>
(3) Where urgent responses are necessary due to the anticipated domestic transmission or epidemic of any infectious disease, a disease control officer shall have authority to take measures against the fields of an infectious disease, such as the restriction of passage, the evacuation of residents, the disposal and incarnation of food, things, etc., through which an infectious disease is transmitted, the assignment of tasks on personnel in charge of infectious disease control including medical personnel, and the deployment of supplies for disease control, for conducting affairs prescribed in Article 4 (2) 1 and 2.
(4) Relevant public officials, such as the head of a police agency prescribed in Articles 12 and 13 of the Act on the Organization and Operation of National Police and Autonomous Police, the head of a fire-fighting government office prescribed in Article 3 of the Framework Act on Firefighting Services, and the director of a public health center prescribed in Article 10 of the Regional Public Health Act, all of which have jurisdiction over an area of an infectious disease, and corporations, organizations, and individuals located in that area shall cooperate in measures taken by a disease control officer under paragraph (3) without good cause. <Amended on Dec. 22, 2020>
(5) Except as provided in paragraphs (1) through (4), matters necessary for the qualification and duties of disease control officers, the scope of their authority to take measures, and other relevant matters shall be prescribed by Presidential Decree.
[This Article Wholly Amended on Jul. 6, 2015]
 Article 60-2 (Epidemiological Investigation Officers)
(1) Epidemiological investigation officers shall be composed of at least 100 public officials of the Korea Disease Control and Prevention Agency and at least two public officials of a City/Do, respectively, to deal with affairs concerning epidemiological investigations. In such cases, at least one of the City/Do epidemiological investigation officers shall be a physician, among the medical personnel referred to in Article 2 (1) of the Medical Service Act. <Amended on Mar. 27, 2018; Mar. 4, 2020; Aug. 11, 2020>
(2) Where necessary for dealing with affairs concerning epidemiological investigations, the head of a Si/Gun/Gu may have epidemiological investigation officers as public officials of said Si/Gun/Gu: Provided, That the head of a Si/Gun/Gu that meets the criteria prescribed by Ministerial Decree of Health and Welfare in consideration of the population, etc. shall have at least one epidemiological investigation officer as a public official of said Si/Gun/Gu. <Added on Mar. 4, 2020>
(3) Epidemiological investigation officers under paragraphs (1) and (2) shall be appointed, from among any of the following persons who have completed education and training courses on epidemiological investigations under Article 18-3: <Amended on Mar. 4, 2020; May 19, 2023>
1. Public officials who take charge of disease control, epidemiological investigation, or vaccination services;
2. Medical personnel defined in Article 2 (1) of the Medical Service Act.
3. Other experts in fields related to infectious diseases and epidemiology, such as pharmacists prescribed in subparagraph 2 of Article 2 of the Pharmaceutical Affairs Act and veterinarians prescribed in subparagraph 1 of Article 2 of the Veterinarians Act.
(4) Where the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu needs to require a public official under his or her control to complete education and training courses on epidemiological investigations under Article 18-3 so as to appoint the public official as an epidemiological investigation officer, he or she shall appoint the relevant public official as an epidemiological investigation officer trainee. <Added on May 19, 2023>
(5) An epidemiological investigation officer may temporarily take the measures specified under the items of subparagraph 1 of Article 47, where an emergency, in which the spread of an infectious disease is anticipated, would be likely to cause a serious harm to public health if measures thereagainst are not taken immediately: Provided, That epidemiological investigation officer trainees may temporarily take the measures under the items of subparagraph 1 of Article 47, only if under the command of disease control officers or epidemiological investigation officers. <Amended on Mar. 4, 2020; May 19, 2023>
(6) Relevant public officials, such as the head of a police agency under Articles 12 and 13 of the Act on the Organization and Operation of National Police and Autonomous Police, the head of a firefighting government office under Article 3 of the Framework Act on Firefighting Services, and the director of a public health center under Article 10 of the Regional Public Health Act, shall cooperate in measures taken by an epidemiological investigation officer or an epidemiological investigation officer trainee under paragraph (5) without good cause. <Amended on Mar. 4, 2020; Dec. 22, 2020; May 19, 2023>
(7) Where an epidemiological investigation officer or an epidemiological investigation officer trainee takes the measures under paragraph (5), he or she shall immediately report such fact to the Commissioner of the Korea Disease Control and Prevention Agency, the competent Mayor/Do Governor, or the head of the competent Si/Gun/Gu. <Amended on Mar. 4, 2020; Aug. 11, 2020; May 19, 2023>
(8) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may subsidize epidemiological investigation officers and epidemiological investigation officer trainees appointed pursuant to paragraphs (1), (2) and (4) for expenses necessary to perform their duties, etc., within the budget. <Amended on Mar. 4, 2020; Aug. 11, 2020; May 19, 2023>
(9) Except as provided in paragraphs (1) through (8), matters necessary for the qualification, duties, authority of epidemiological investigation officers and epidemiological investigation officer trainees, subsidization therefor, etc. shall be prescribed by Presidential Decree. <Amended on Mar. 4, 2020; May 19, 2023>
[This Article Added on Jul. 6, 2015]
 Article 60-3 (Temporary Duty Orders)
(1) Where an infectious disease is likely to be transmitted into or epidemic in the Republic of Korea, or already breaks out, the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor may order any medical personnel prescribed in Article 2 (1) of the Medical Service Act to perform disease control duties for a specified period at a medical institution designated as an infectious disease control institution under Article 36 or 37, or the Central Infectious Disease Hospital or a regional infectious disease hospital established or designated under Article 8-2. <Amended on Aug. 11, 2020; Aug. 16, 2023>
(2) In emergency situations where an infectious disease is transmitted into or epidemic in the Republic of Korea, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor or the head of a Si/Gun/Gu may appoint any person falling under Article 60-2 (3) 2 or 3 as a disease control officer to perform disease control duties for a specified period. <Amended on Mar. 4, 2020; Aug. 11, 2020; Sep. 29, 2020>
(3) Where epidemiological investigation personnel are undermanned due to the transmission or epidemic of an infectious disease, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may appoint any person falling under Article 60-2 (3) 2 or 3 as an epidemiological investigation officer to perform duties related to epidemiological investigations for a specified period. <Amended on Mar. 4, 2020; Aug. 11, 2020>
(4) A disease control officer or epidemiological investigation officer appointed by the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu under paragraph (2) or (3) shall be deemed appointed as a public official in a fixed term position defined in Article 26-5 of the State Public Officials Act. <Amended on Mar. 4, 2020; Aug. 11, 2020>
(5) Matters necessary for temporary duty orders issued under paragraph (1), and the period, procedures, etc. for appointment under paragraphs (2) and (3) shall be prescribed by Presidential Decree.
[This Article Added on Dec. 29, 2015]
 Article 61 (Quarantine Inspection Commissioners)
(1) Where necessary for the prevention of infectious diseases, a Mayor/Do Governor may appoint a quarantine inspection commissioner to perform affairs concerning quarantine inspections, and if particularly necessary, may require the commissioner to quarantine any means of transportation, etc.
(2) Quarantine inspection commissioners may board any means of transportation, etc. free of charge to perform affairs or quarantine inspections stipulated under paragraph (1).
(3) Matters necessary for the appointment, duties, etc. of quarantine inspection commissioners under paragraph (1), shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 62 (Disease Prevention Commissioners)
(1) Where an infectious disease is epidemic or likely to be epidemic, a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may appoint a disease prevention commissioner at the relevant Special Self-Governing City, Special Self-Governing Province or Si/Gun/Gu (referring to an autonomous Gu; hereinafter the same shall apply) to perform affairs concerning the prevention of infectious diseases. <Amended on Jun. 13, 2023>
(2) Disease prevention commissioners appointed under paragraph (1) shall serve without compensation: Provided, That a paid disease prevention commissioner may be appointed at the rate of one commissioner per 20,000 population of the Special Self-Governing City, Special Self-Governing Province or Si/Gun/Gu. <Amended on Jun. 13, 2023>
(3) Matters necessary for the appointment, duties, etc. of disease prevention commissioners referred to in paragraph (1), shall be determined by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010>
 Article 63 (Korea Association of Health Promotion)
(1) The Korea Association of Health Promotion (hereinafter referred to as the "Association") shall be established to perform prevention projects including investigations and research on parasitic diseases defined in subparagraph 6 of Article 2. <Amended on Mar. 27, 2018>
(2) The Association shall be a corporation.
(3) Except as provided in this Act, the provisions concerning incorporated associations under the Civil Act shall apply mutatis mutandis to the Association.
CHAPTER X EXPENSES
 Article 64 (Expenses to Be Borne by Special Self-Governing City, Special Self-Governing Province and Si/Gun/Gu)
The following expenses shall be borne by the relevant Special Self-Governing City, Special Self-Governing Province or Si/Gun/Gu: <Amended on Jul. 6, 2015; Dec. 29, 2015; Aug. 12, 2020; Sep. 29, 2020; Jun. 13, 2023>
1. Some expenses incurred in providing support to corporations or associations which perform preventive and treatment duties of Hansen's disease pursuant to Article 4 (2) 13;
2. Expenses incurred in conducting vaccinations pursuant to Articles 24 (1) and 25 (1);
3. All or some expenses incurred by medical institutions in conducting vaccinations pursuant to Articles 24 (2) and 25 (2);
4. Expenses incurred by infectious disease control institutions designated by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu in establishing and operating infectious disease control facilities pursuant to Article 36;
5. Expenses incurred in establishing and operating isolation wards, sanatoriums, or clinics established by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu pursuant to Article 37, and infectious disease control facilities of infectious disease control institutions designated under that Article;
6. Subsidization for ensuring the minimum security level defined in subparagraph 6 of Article 2 of the National Basic Living Security Act to those who suffer difficulties in livelihood due to a traffic blockage or hospitalization under subparagraph 1 or 3 of Article 47;
7. Expenses incurred in disinfection or other measures conducted or taken by a Special Self-Governing City, a Special Self-Governing Province and a Si/Gun/Gu pursuant to Articles 47, 48, 49 (1) 8, 9, and 13, and 51 (1);
8. Allowances, treatment expenses, or compounding fees for assigning physicians and for mobilizing medical persons, medical practitioners, and other medical personnel by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu pursuant to Article 49 (1) 7 and 12;
8-2. Expenses including expenses incurred in operating facilities, such as sickbeds of medical institutions, training institutes and accommodation facilities mobilized by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu pursuant to Article 49 (1) 12-2;
9. Expenses incurred in supplying potable water pursuant to Article 49 (2);
10. Expenses incurred in assigning disease prevention commissioners pursuant to Article 62;
10-2. Expenses incurred by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu in providing psychological support under Article 70-6 (1);
10-3. Expenses incurred by relevant specialized institutions in providing psychological support under entrustment by a Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu pursuant to Article 70-6 (2);
11. Other expenses incurred in conducing affairs concerning the prevention of infectious diseases by a Special Self-Governing City, a Special Self-Governing Province and a Si/Gun/Gu pursuant to this Act.
[Title Amended on Jun. 13, 2023]
 Article 65 (Expenses to Be Borne by Cities/Dos)
The following expenses shall be borne by Cities/Dos: <Amended on Dec. 29, 2015; Mar. 27, 2018; Aug. 12, 2020; Sep. 29, 2020; Dec. 15, 2020; Sep. 14, 2023>
1. Some expenses incurred in providing support to corporations or associations which perform preventive and treatment duties of Hansen's disease pursuant to Article 4 (2) 13;
1-2. Expenses incurred in City/Do crisis response training under Article 35 (2);
2. Expenses incurred by infectious disease control institutions designated by a Mayor/Do Governor pursuant to Article 36 in establishing and operating their infectious disease control facilities;
3. Expenses incurred in establishing and operating isolation wards, sanatoriums, or clinics established by a Mayor/Do Governor pursuant to Article 37, and infectious disease control facilities of infectious disease control institutions designated under that Article;
3-2. Expenses incurred in establishing and operating facilities for quarantining persons suspected of contracting an infectious disease designated by a Mayor/Do Governor pursuant to Article 39-3;
4. Expenses incurred in the inpatient treatment, investigations, medical diagnoses, etc. of Korean patients of an infectious disease, etc. under Articles 41 and 42;
5. Expenses incurred in conducting medical examinations, vaccination, etc. pursuant to Article 46;
6. Subsidization for ensuring the minimum security level defined in subparagraph 6 of Article 2 of the National Basic Living Security Act to those who suffer difficulties in livelihood due to the traffic blockage under Article 49 (1) 1;
6-2. Allowances, treatment expenses, or compounding fees for mobilizing medical persons, medical practitioners, and other medical personnel by a Mayor/Do Governor pursuant to Article 49 (1) 12;
6-3. Expenses including expenses incurred in operating facilities, such as sickbeds of medical institutions, training institutes and accommodation facilities mobilized by the Mayor/Do Governor pursuant to Article 49 (1) 12-2;
7. Expenses incurred in supplying potable water pursuant to Article 49 (2);
7-2. Allowances and other expenses incurred in assigning medical persons, etc. to disease control duties by a Mayor/Do Governor pursuant to Article 60-3 (1) and (3);
8. Expenses incurred in assigning quarantine inspection commissioners pursuant to Article 61;
8-2. Expenses incurred by a Mayor/Do Governor in providing psychological support under Article 70-6 (1);
8-3. Expenses incurred by relevant specialized institutions in providing psychological support under entrustment by a Mayor/Do Governor pursuant to Article 70-6 (2);
9. Other expenses incurred in conducting affairs concerning the prevention of infectious diseases by a City/Do pursuant to this Act.
 Article 66 (Expenses to Be Subsidized by City/Do)
A City/Do (excluding a Special Self-Governing City and a Special Self-Governing Province) shall subsidize expenses to be borne by respective Si/Gun/Gu pursuant to Article 64, as prescribed by Presidential Decree. <Amended on Jun. 13, 2023>
 Article 67 (Expenses to Be Borne by National Treasury)
The following expenses shall be borne by the National Treasury: <Amended on Jan. 18, 2010; Jul. 6, 2015; Dec. 29, 2015; Mar. 27, 2018; Dec. 3, 2019; Mar. 4, 2020; Aug. 11, 2020; Aug. 12, 2020; Sep. 29, 2020; Dec. 15, 2020; Sep. 14, 2023>
1. Expenses incurred in the medical treatment and protection of patients of an infectious disease, etc. under Article 4 (2) 2;
2. Expenses incurred in the education and publicity of infectious diseases under Article 4 (2) 4;
3. Expenses incurred in nurturing specialists for the prevention of infectious diseases under Article 4 (2) 8;
4. Expenses incurred in conducting sentinel surveillance activities under Article 16 (4);
4-2. Expenses incurred in conducting education and training under Article 18-3;
5. Expenses incurred in transporting corpses for autopsies under Article 20, and in disposal of them after autopsies;
5-2. Expenses incurred in conducting funerals for the deceased persons under Article 20-2;
6. Expenses incurred in the production, research, etc., of vaccines under Article 33;
6-2. Expenses incurred in stockpiling mandatory vaccines, etc. under Article 33-2 (1);
6-3. Expenses incurred in the State's crisis response training under Article 34 (2) 5;
6-4. Expenses incurred by infectious disease control institutions designated by the Minister of Health and Welfare or the Commissioner of the Korea Disease Control and Prevention Agency in establishing and operating their infectious disease control facilities pursuant to Article 36 (1);
7. Expenses incurred in establishing and operating isolation wards, sanatoriums, or clinics established by the Minister of Health and Welfare or the Commissioner of the Korea Disease Control and Prevention Agency pursuant to Article 37, and infectious disease control facilities of infectious disease control institutions designated under that Article;
7-2. Expenses incurred in establishing and operating facilities for quarantining persons suspected of contracting an infectious disease designated by the Commissioner of the Korea Disease Control and Prevention Agency pursuant to Article 39-3;
8. Expenses incurred in stockpiling and concluding contracts for long-term purchase of medicines and equipment found necessary after undergoing deliberation by the Committee pursuant to Article 40 (1);
9. Deleted; <Aug. 12, 2020>
9-2. Allowances, medical costs, or compounding fees for mobilizing medical persons, medical practitioners, and other medical personnel by the State pursuant to Article 49 (1) 12;
9-3. Expenses including expenses incurred in operating facilities, such as sickbeds of medical institutions, training institutes and accommodation facilities mobilized by the State pursuant to Article 49 (1) 12-2;
9-4. Allowances and other expenses incurred in assigning medical persons, etc. to disease control duties by the State pursuant to Article 60-3 (1) through (3);
9-5. Expenses incurred by the State in providing psychological support under Article 70-6 (1);
9-6. Expenses incurred by relevant specialized institutions in providing psychological support under entrustment by the State pursuant to Article 70-6 (2);
10. Expenses incurred in compensating injuries caused by vaccinations, etc. under Article 71.
 Article 68 (Expenses to Be Subsidized by the State)
The State shall subsidize the following expenses:
1. Some expenses incurred in providing support to corporations or associations which perform preventive and treatment duties of Hansen's disease pursuant to Article 4 (2) 13;
2. At least 1/2 of expenses to be borne by Cities/Dos pursuant to Articles 65 and 66.
 Article 69 (Expenses Collectible from Patients)
A Special Self-Governing City Mayor, a Special Self-Governing Province Governor or the head of a Si/Gun/Gu may collect expenses incurred in hospitalization, medical diagnosis, examination, treatment, etc. due to a person's chronic disease, newly-diagnosed disease, etc., other than expenses incurred in inpatient treatment under Articles 41 and 42, from the person or his or her guardian, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Jan. 18, 2010; Jun. 13, 2023>
 Article 69-2 (Expenses Borne by Foreigners)
The Commissioner of the Korea Disease Control and Prevention Agency may require a patient, etc. with an infectious disease who is a foreigner or a person suspected of contracting an infectious disease to bear all or part of the following expenses, taking into account international practices, the principle of reciprocity, etc.: Provided, That the foregoing shall not apply to foreigners confirmed to have been infected with an infectious disease in Korea:
1. Expenses for treatment under Article 41;
2. Expenses for investigation, diagnosis, treatment, hospitalization and quarantine under Article 42.
[This Article Added on Aug. 12, 2020]
 Article 70 (Compensation for Losses)
(1) The Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall pay compensation to a person suffering from any of the following losses, according to the results of deliberation and resolution by the relevant Compensation Deliberation Committee established under Article 70-2: <Amended on Dec. 29, 2015; Mar. 27, 2018; Aug. 11, 2020; Aug. 12, 2020; Dec. 15, 2020>
1. Loss resulting from the designation of an infectious disease control institution or the establishment and operation of an isolation ward, etc. under Article 36 or 37;
1-2. Loss resulting from the establishment and operation of facilities for quarantining persons suspected of contracting an infectious disease under Article 39-3;
2. Loss suffered by a medical institution who has given medical treatment to patients or probable patients of an infectious diseases, etc. in accordance with any measure taken under this Act;
3. Loss suffered by a medical institution due to its closure, suspension of business, etc. under this Act;
4. Loss resulting from a measure taken under subparagraph 1, 4, or 5 of Article 47, Article 48 (1), or Article 49 (1) 4, 6 through 10, 12, 12-2, or 13;
5. Loss equivalent to any loss specified in subparagraphs 1 through 4, which is suffered by a health care institution defined in Article 42 of the National Health Insurance Act due to the occurrence or visitation of a patient of an infectious disease, etc. or due to the disclosure thereof by the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu, and the compensation for which is deliberated and resolved by the relevant Compensation Deliberation Committee established under Article 70-2.
(2) Any person seeking compensation for loss under paragraph (1) shall file a claim for compensation for loss with the Minister of Health and Welfare, the relevant Mayor/Do Governor, or the head of the relevant Si/Gun/Gu, by appending relevant documents to the written claim for compensation for loss, as prescribed by Ministerial Decree of Health and Welfare. <Amended on Dec. 29, 2015>
(3) In determining the amount of compensation under paragraph (1), if the person who has suffered a loss caused or expanded the loss in violation of obligation to take measures under this Act or the relevant statutes or regulations, the Minister of Health and Welfare, the relevant Mayor/Do Governor, or the head of the relevant Si/Gun/Gu may choose not to pay the relevant compensation, or may reduce the amount thereof. <Added on Dec. 29, 2015>
(4) Matters necessary for the subject matter and extent of compensation and the determination of the amount of compensation to be paid under paragraph (1), standards for choosing the non-payment of compensation and reducing the amount thereof under paragraph (3), and other relevant matters shall be prescribed by Presidential Decree. <Added on Dec. 29, 2015>
 Article 70-2 (Compensation Deliberation Committee)
(1) In order to deliberate and resolve on issues regarding compensation provided for in Article 70, a Compensation Deliberation Committee (hereinafter referred to as "Deliberation Committee") shall be established under the Ministry of Health and Welfare and each City/Do.
(2) A Deliberation Committee shall be comprised of not exceeding 20 members, including two chairpersons; the Deliberation Committee established under the Ministry of Health and Welfare shall be co-chaired by the Vice Minister of Health and Welfare and a non-governmental member; and a Deliberation Committee established in each City/Do shall be co-chaired by its Vice Mayor/Governor and a non-governmental member.
(3) Members of a Deliberation Committee shall be appointed or commissioned by the Minister of Health and Welfare or the competent Mayor/Do Governor, from among persons with extensive knowledge of and experience in the relevant fields and related public officials, as prescribed by Presidential Decree.
(4) If required for a deliberation and resolution process under paragraph (1), a Deliberation Committee may request interested parties to attend a Committee meeting or to submit data.
(5) Other matters necessary for the composition, operation, etc., of Deliberation Committees shall be prescribed by Presidential Decree.
[This Article Added on Dec. 29, 2015]
 Article 70-3 (Financial Support for Health and Medical Services Personnel)
(1) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, and the head of a Si/Gun/Gu may subsidize the medical persons, founders of medical institutions, or pharmacists who have supported activities for the surveillance, prevention, control, or epidemiological investigation of an infectious disease under this Act, within the budget. <Amended on Aug. 11, 2020; Dec. 15, 2020>
(2) Where a crisis alert of serious level or higher is issued under Article 38 (2) of the Framework Act on the Management of Disasters and Safety due to the spread of infectious diseases, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may provide financial support to the health and medical services personnel working in health and medical institutions (referring to the health and medical services personnel defined in subparagraph 3 of Article 2 of the Act on Support for Health and Medical Services Personnel and the staff working in health and medical institutions defined in 4 of that Article) who provide assistance to the affairs related to monitoring the outbreak of infectious diseases, and the prevention, quarantine, examination, treatment, management, and epidemiological investigation of the infectious disease cases pursuant to this Act, within the budget. <Added on Dec. 21, 2021>
(3) Matters necessary for the details, procedures, methods, etc. of support under paragraphs (1) and (2) shall be prescribed by Presidential Decree. <Amended on Dec. 21, 2021>
[This Article Added on Dec. 29, 2015]
[Title Amended on Dec. 15, 2020; Dec. 21, 2021]
 Article 70-4 (Livelihood Assistance for Patients of Infectious Disease)
(1) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, and the head of a Si/Gun/Gu may provide treatment expenses, livelihood assistance, and other financial support to persons hospitalized, quarantined, or isolated under this Act, within the budget. <Amended on Aug. 11, 2020>
(2) Where a person specified in paragraph (1) or a medical person specified in Article 70-3 (1) is unable to care for his or her child because of hospitalization, quarantine, or isolation, or support for surveillance, prevention, control, or epidemiological investigation of an infectious disease, the relevant Mayor/Do Governor and the head of the relevant Si/Gun/Gu shall take necessary measures, including child-care support defined under the Child-Care Support Act.
(3) Matters necessary for providing assistance and support under paragraphs (1) and (2) shall be prescribed by Presidential Decree.
[This Article Added on Dec. 29, 2015]
 Article 70-5 (Emergency Support of Compensation for Loss)
The Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu may preferentially pay compensation for loss under Article 70 (1) to a person who has suffered a loss falling under any subparagraph of Article 70 (1) and thereby in need of urgent funding support due to economic difficulty, subject to deliberation and resolution by the Deliberation Committee.
[This Article Added on Sep. 29, 2020]
 Article 70-6 (Psychological Support)
(1) The Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu may provide psychological support defined in Article 15-2 of the Act on the Improvement of Mental Health and the Support for Welfare Services for Mental Patients (hereinafter referred to as "psychological support") to patients of an infectious disease, etc., their families, persons suspected of contracting an infectious disease, medical personnel responding to infectious diseases, and other on-site response personnel.
(2) The Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu may delegate or entrust psychological support to the National Trauma Center under Article 15-2 of the Act on the Improvement of Mental Health and the Support for Welfare Services for Mental Patients or a specialized institution prescribed by Presidential Decree.
(3) Matters necessary for the scope of on-site response personnel under paragraph (1) and psychological support under paragraph (2) shall be prescribed by Presidential Decree.
[This Article Added on Sep. 29, 2020]
 Article 71 (Compensation by the State for Injury Caused by Vaccination)
(1) Where a person who has been vaccinated pursuant to Articles 24 and 25, or a person who has been administered a preventive and therapeutic medicine pursuant to Article 40 (2) contracts a disease, becomes disabled, or dies due to such vaccination or preventive and therapeutic medicine, the State shall pay the following compensation according to the standards and procedures prescribed by Presidential Decree:
1. A person who receives treatment for a disease: All medical expenses and a fixed amount of nursing expenses;
2. A person who becomes disabled: A lump-sum compensation;
3. A deceased person: A lump-sum compensation for the bereaved family members and funeral expenses prescribed by Presidential Decree.
(2) A disease, disability, or death eligible for the compensation under paragraph (1) shall be limited to cases recognized by the Commissioner of the Korea Disease Control and Prevention Agency, in which injury is caused by vaccination or administration of a preventive and therapeutic medicine, regardless of abnormality of the relevant vaccine, or negligence of the person who performed vaccination or administered the relevant preventive or therapeutic medicine. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(3) The Commissioner of the Korea Disease Control and Prevention Agency shall determine whether a filed case is applicable to a disease, disability, or death under paragraph (2) within 120 days from the date a claim for compensation under paragraph (1) is filed. In such cases, he or she shall hear the opinions of the Committee in advance. <Amended on Jan. 18, 2010; Aug. 11, 2020>
(4) Matters necessary for the claims for compensation under paragraph (1), the methods of and procedures for determination under paragraph (3), and other relevant matters shall be prescribed by Presidential Decree.
 Article 72 (Relationship to Claim for Damages)
(1) Where the State has paid compensations for injury under Article 71 due to any abnormal vaccine, or an intentional or negligent conduct of a third party, including a person, etc. who performed vaccination or administered a preventive and therapeutic medicine, the State shall subrogate the relevant recipient of such compensation to a claim for damages against the third party, to the extent of the amount of such paid compensation.
(2) Where a person who has been vaccinated or administered a preventive and therapeutic medicine, or his or her bereaved family member referred to in Article 71 (1) 3 has been paid compensations by a third party, the State shall not pay any of the compensations referred to in Article 71, to the extent of the amount of such paid compensation, and where the State has erroneously paid compensation, it may collect the relevant amount in the same manner as national taxes.
 Article 72-2 (Claim for Damages)
The Minister of Health and Welfare, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall have the right to claim damages for expenses incurred in hospitalization, quarantine, diagnosis, compensation for loss, etc. against a person who spreads an infectious disease or increases the risk of transmission in violation of this Act.
[This Article Added on Mar. 9, 2021]
 Article 73 (Prohibition from Transferring Entitlement to Compensation by the State)
No entitlement to compensation pursuant to Articles 70 and 71 may be transferred or seized.
CHAPTER XI SUPPLEMENTARY PROVISIONS
 Article 74 (Prohibition of Divulgence of Confidential Information)
No person who is or has been engaged in duties relevant to infectious diseases, such as medical examinations, inpatient treatment, diagnosis, etc. under this Act shall divulge any confidential information he or she has obtained in the course of performing his or her duties to any third person or use such information for any purpose other than the performance of his or her duties. <Amended on Sep. 29, 2020>
 Article 74-2 (Request for Providing Materials, and Inspection)
(1) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may request the heads of infectious disease control institutions, etc., to provide materials concerning the establishment and operation of infectious disease control facilities, and isolation wards, sanatoriums, or clinics prescribed in Article 37, or facilities for quarantining persons suspected of contracting an infectious disease prescribed in Article 39-3, and may require public officials under his or her jurisdiction to enter the relevant facilities and inspect related documents, facilities, equipment, etc., and to make inquiries to relevant persons. <Amended on Mar. 27, 2018; Aug. 11, 2020; Dec. 15, 2020>
(2) A public official who enters and conducts inspections pursuant to paragraph (1) shall carry an identification indicating his or her authority and produce it to relevant persons.
[This Article Added on Jul. 6, 2015]
 Article 75 (Hearings)
When intending to issue any of the following dispositions, a Mayor/Do Governor or the head of a Si/Gun/Gu shall hold a hearing thereon:
1. An order to close a place or facility under Article 49 (3);
2. An order to close a place of business under Article 59 (1).
[This Article Wholly Amended on Mar. 9, 2021]
 Article 76 (Delegation or Entrustment)
(1) The authority and duty of the Minister of Health and Welfare stipulated under this Act may be partially delegated to the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor or be partially entrusted to relevant institutions or organizations, as prescribed by Presidential Decree.
(2) The authority and duty of the Commissioner of the Korea Disease Control and Prevention Agency stipulated under this Act may be partially delegated to a Mayor/Do Governor or be partially entrusted to relevant institutions or organizations, as prescribed by Presidential Decree.
[This Article Wholly Amended on Aug. 11, 2020]
 Article 76-2 (Request for Provision of Information and Verification of Information)
(1) If necessary to prevent and control infectious diseases and block the spread of infection, the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor may request the heads of relevant central administrative agencies (including affiliated agencies and responsible administrative agencies thereof), the heads of local governments (including the superintendents of education prescribed in Article 18 of the Local Education Autonomy Act), public institutions designated under Article 4 of the Act on the Management of Public Institutions, medical institutions, pharmacies, corporations, organizations, and individuals to provide the following information concerning patients of infectious diseases, etc., persons suspected of contracting an infectious disease, and persons vaccinated, and persons in receipt of such request shall comply therewith: <Amended on Dec. 2, 2016; Mar. 4, 2020; Aug. 11, 2020; Sep. 29, 2020; Mar. 28, 2023>
1. Personal information, such as names, resident registration numbers prescribed in Article 7-2 (1) of the Resident Registration Act, addresses, and telephone numbers (including cell phone numbers);
2. Prescriptions prescribed in Article 17 of the Medical Service Act and medical records, etc. prescribed in Article 22 of that Act;
3. Information prescribed by Presidential Decree as necessary for preventing and controlling infectious diseases, such as severity levels of disability, types of disability, and income distribution, among information about the insured and their dependents under Article 5 of the National Health Insurance Act or eligible recipients under Article 3 of the Medical Benefit Act;
4. Information, such as medical records, medicines, injuries and diseases, prescribed by Presidential Decree, regarding claims for and payment of costs of health care benefits under Article 47 of the National Health Insurance Act, and regarding claims for and granting of expenses for benefits under Article 11 of the Medical Benefit Act;
5. Records of immigration control during the period determined by the Commissioner of the Korea Disease Control and Prevention Agency;
6. Other information prescribed by Presidential Decree for monitoring the movement paths of such patients, etc.
(2) If necessary to prevent and control infectious diseases and block the spread of infection, the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu may request the Commissioner General of the Korean National Police Agency, the commissioner of a City/Do police agency, or the chief of a police station referred to in Article 2 of the Act on the Organization and Operation of National Police and Autonomous Police (hereafter in this Article referred to as "police agency") to provide location information of patients of an infectious disease, etc. and persons suspected of contracting an infectious disease. In such cases, notwithstanding Article 15 of the Act on the Protection and Use of Location Information and Article 3 of the Protection of Communications Secrets Act, the head of the relevant police agency, upon request by the Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu, may request any personal location information provider defined in Article 5 (7) of the Act on the Protection and Use of Location Information and any telecommunications business operator defined in subparagraph 8 of Article 2 of the Telecommunications Business Act to provide location information of patients of an infectious disease, etc. and persons suspected of contracting an infectious disease; and the personal location information provider and the telecommunications business operator in receipt of such request shall comply therewith unless there is good cause. <Amended on Dec. 29, 2015; Apr. 17, 2018; Mar. 4, 2020; Aug. 11, 2020; Dec. 22, 2020; Mar. 28, 2023>
(3) The Commissioner of the Korea Disease Control and Prevention Agency may provide information collected pursuant to paragraphs (1) and (2) to the heads of the relevant central administrative agencies, the heads of local governments, the President of the National Health Insurance Service, the President of the Health Insurance Review and Assessment Service, health and medical services institutions defined in subparagraph 4 of Article 3 of the Framework Act on Health and Medical Services (hereinafter referred to as "health and medical services institutions"), other organizations, etc. In such cases, information provided to health and medical services institutions, etc. shall be limited to information related to the affairs of the relevant institutions, etc. for preventing and controlling infectious diseases and blocking the spread of infection. <Amended on Mar. 4, 2020; Aug. 11, 2020; Mar. 28, 2023>
(4) Notwithstanding the former part of paragraph (3), if necessary to prevent and control infectious diseases and block the spread of infection, the Commissioner of the Korea Disease Control and Prevention Agency shall provide information prescribed in paragraph (1) 5 and information on movement paths prescribed in subparagraph 6 of that paragraph to health and medical services institutions using any of the following information and communications systems. In such cases, information provided to health and medical services institutions shall be limited to information related to the affairs of the relevant institutions: <Added on Mar. 4, 2020; Aug. 11, 2020; Mar. 28, 2023>
1. The information system of the National Health Insurance Service;
2. The information system of the Health Insurance Review and Assessment Service;
3. The information system of an institution deemed necessary and designated by the Commissioner of the Korea Disease Control and Prevention Agency to prevent any infectious disease from being transmitted into or spreading in the Republic of Korea.
(5) When providing medical treatment or prescribing or preparing medicines, medical personnel, pharmacists, and the heads of health and medical services institutions shall check information provided pursuant to paragraph (4) using an information system prescribed in any subparagraph of that paragraph. <Added on Mar. 4, 2020>
(6) No person provided with information pursuant to paragraphs (3) and (4) shall use such information for any purpose, other than conducting affairs related to infectious diseases under this Act, and shall, without delay, destroy all information after completing the relevant affairs and inform the Commissioner of the Korea Disease Control and Prevention Agency thereof. <Amended on Mar. 4, 2020; Aug. 11, 2020>
(7) The Commissioner of the Korea Disease Control and Prevention Agency, a Mayor/Do Governor, or the head of a Si/Gun/Gu shall notify the subject of information collected pursuant to paragraphs (1) and (2) (hereinafter referred to as “data subject”), of the following facts: <Amended on Mar. 4, 2020; Aug. 11, 2020; Mar. 28, 2023; Jan. 23, 2024>
1. The fact that information necessary for preventing and controlling infectious diseases and blocking the spread of infection has been collected;
2. Where information prescribed in subparagraph 1 has been provided to another agency, such fact;
3. The fact that, even in cases prescribed in subparagraph 2, no information shall be used for any purpose, other than conducting affairs related to infectious diseases under this Act, and all the information shall be destroyed without delay when the relevant affairs are completed.
(8) Where a person provided with information pursuant to paragraphs (3) and (4) processes the relevant information in violation of this Act, such person shall be governed by the Personal Information Protection Act. <Amended on Mar. 4, 2020>
(9) Matters necessary for the target and scope of information provided under paragraph (3), the methods of notification under paragraph (7), and other relevant matters shall be prescribed by Ministerial Decree of Health and Welfare. <Amended on Mar. 4, 2020>
[This Article Added on Jul. 6, 2015]
[Title Amended on Mar. 4, 2020]
 Article 76-3 (Preparation and Disclosure of Personal Information Processing Report)
(1) The Commissioner of the Korea Disease Control and Prevention Agency shall prepare a report on the processing of personal information (hereinafter referred to as "personal information processing report"), including notification to data subjects under Article 76-2 (7), every year.
(2) The Mayor/Do Governor or the head of a Si/Gun/Gu shall submit data related to notification to data subjects under Article 76-2 (7) to the Commissioner of the Korea Disease Control and Prevention Agency.
(3) The Commissioner of the Korea Disease Control and Prevention Agency shall disclose a personal information processing report prepared pursuant to paragraph (1) on the website of the Korea Disease Control and Prevention Agency by the first half of the following year, as prescribed by Ministerial Decree of Health and Welfare.
(4) Matters necessary for the preparation of personal information processing reports and submission of data shall be prescribed by Ministerial Decree of Health and Welfare.
[This Article Added on Jan. 23, 2024]
[Previous Article 76-3 moved to Article 76-4 <Jan. 23, 2024>]
 Article 76-4 (Analysis of and Research on Information on Infectious Diseases)
(1) If necessary for preventing and controlling infectious diseases and blocking the spread of infection, the Commissioner of the Korea Disease Control and Prevention Agency may analyze the following information or use such information for infectious disease-related research:
1. Information collected through reporting under Articles 11 (5) and 13;
2. Information from epidemiological investigations under Article 18;
3. Information on vaccination records under Article 28;
4. Information from epidemiological investigations on vaccination under Article 29;
5. Information provided pursuant to Article 76-2 (1) and (2);
6. Other information necessary for preventing and controlling infectious diseases and blocking the spread of infection, which is determined by the Commissioner of the Korea Disease Control and Prevention Agency.
(2) Where the Commissioner of the Korea Disease Control and Prevention Agency uses personal information pursuant to paragraph (1), he/she shall pseudonymize such information as defined in subparagraph 1-2 of Article 2 of the Personal Information Protection Act (hereafter in this Article, referred to as "pseudonymization"): Provided, That this shall not apply to any of the following cases:
1. Where the assignment of hospital beds and other urgent measures are required, allowing no time for pseudonymization;
2. Where the use of pseudonymized personal information makes it difficult to respond to adverse reactions to vaccinations, control sequelae of infectious diseases, support persons vulnerable to infection, and perform other uninterrupted work.
(3) Where any personal information is used pursuant to paragraph (1), matters necessary for the legal basis, purposes, scope, etc. thereof shall be published in the Official Gazette or on the website pursuant to Article 18 (4) of the Personal Information Protection Act: Provided, That this shall not apply where pseudonymized information is used pursuant to the main clause, with the exception of the subparagraphs, of paragraph (2).
[This Article Added on Mar. 28, 2023]
[Moved from Article 76-3; previous Article 76-4 moved to Article 76-5 <Jan. 23, 2024>]
 Article 76-5 (Provisions Applicable Mutatis Mutandis)
Article 42 (6) shall apply mutatis mutandis to hospitalization or quarantine or isolation pursuant to Article 41 (1), subparagraph 3 of Article 47, and Article 49 (1) 14. <Amended on Aug. 12, 2020>
[This Article Added on Mar. 4, 2020]
[Moved from Article 76-4; previous Article 76-5 to Article 76-6 <Jan. 23, 2024>]
 Article 76-6 (Legal Fiction as Public Officials for Purposes of Applying Penalty Provisions)
A non-public official member of the Deliberation Committee shall be deemed a public official for the purposes of penalty provisions pursuant to Articles 127 and 129 through 132 of the Criminal Act.
[This Article Added on Mar. 4, 2020]
[Moved from Article 76-5 <Jan. 23, 2024>]
CHAPTER XII PENALTY PROVISIONS
 Article 77 (Penalty Provisions)
Any of the following persons shall be punished by imprisonment with labor for not more than five years, or by a fine not exceeding 50 million won: <Amended on Dec. 15, 2020>
1. A person who introduces high-risk pathogens into the domestic environment without obtaining permission therefor, in violation of Article 22 (1) or (2);
2. A person who possesses any infectious pathogens spread through bioterrorism without obtaining permission therefor, in violation of Article 23-3 (1);
3. A person who exports medical and quarantine supplies or ships them out of the Republic of Korea, in violation of Article 40-3 (1).
[This Article Wholly Amended on Mar. 4, 2020]
 Article 78 (Penalty Provisions)
Any of the following persons shall be punished by imprisonment with labor for not more than three years or by a fine not exceeding 30 million won: <Amended on Dec. 12, 2017; Dec. 3, 2019; Sep. 29, 2020>
1. A person who establishes and operates a facility handling high-risk pathogens without obtaining permission prescribed in Article 23 (2) or without obtaining permission for modification prescribed in the main clause of paragraph (3) of that Article;
2. A person who fails to obtain permission for modification prescribed in Article 23-3 (3);
3. A person who divulges any secret which comes to his or her knowledge in the course of performing his or her duties or uses them for any purpose other than the performance of his or her duties in violation of Article 74.
 Article 79 (Penalty Provisions)
Any of the following persons shall be punished by imprisonment with labor for not more than two years or by a fine not exceeding 20 million won: <Amended on Jul. 6, 2015; Dec. 12, 2017; Dec. 3, 2019; Mar. 4, 2020; Mar. 9, 2021>
1. A person who violates Article 18 (3);
2. A person who fails to file a report prescribed in Article 21 (1) through (3) or 22 (3) or files a false report;
2-2. A person who refuses, obstructs, or evades an on-site inspection prescribed in Article 21 (5) without good cause;
2-3. A person who establishes and operates a facility handling high-risk pathogens without filing a report prescribed in Article 23 (2);
3. A person who refuses, obstructs, or evades an inspection for safety control prescribed in Article 23 (8);
3-2. A person who violates an order to close, or suspend the operation of, a facility handling high-risk pathogens prescribed in Article 23-2;
3-3. A person who fails to comply with an order of closure without good cause, in violation of Article 49 (4);
4. A person who violates Article 60 (4) (except for public officials);
5. A person who violates Article 76-2 (6).
 Article 79-2 (Penalty Provisions)
Any of the following persons shall be punished by imprisonment with labor for not more than one year or by a fine not exceeding 20 million won: <Amended on Dec. 3, 2019; Sep. 29, 2020; May 19, 2023>
1. Upon receipt of a request for submission of data by the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor under Article 18-4 (2), a person who refuses, obstructs, or evades such requests, who submits false data, or who intentionally omits or conceals any fact, in violation of Article 18-4 (4);
2. A person who handles high-risk pathogens, in violation of Article 23-4 (1);
3. A person who has another person handle high-risk pathogens, in violation of Article 23-4 (2);
4. A medical institution or pharmacy, corporation, organization, or individual that refuses to comply with a request by the Commissioner of the Korea Disease Control and Prevention Agency or a Mayor/Do Governor or that provides false data, in violation of Article 76-2 (1);
5. A person who refuses to comply with a request made by the head of a police agency or provides false data, in violation of the latter part of Article 76-2 (2).
[This Article Added on Dec. 29, 2015]
 Article 79-3 (Penalty Provisions)
Any of the following persons shall be punished by imprisonment with labor for not more than one year or by a fine not exceeding 10 million won: <Amended on Aug. 12, 2020>
1. A person who fails to receive inpatient treatment, in violation of Article 41 (1);
2. Deleted; <Aug. 12, 2020>
3. A person who refuses self-care, facility treatment or inpatient treatment at medical institutions, in violation of Article 41 (2);
4. A person who refuses hospitalization, quarantine, or isolation prescribed in Article 42 (1), (2) 1, (3), or (7);
5. A person who violates any measure for hospitalization, quarantine, or isolation prescribed in subparagraph 3 of Article 47 or 49 (1) 14.
[This Article Added on Mar. 4, 2020]
[Previous Article 79-3 moved to Article 79-4 <Mar. 4, 2020>]
 Article 79-4 (Penalty Provisions)
A person falling under any of the following subparagraphs shall be punished by a fine not exceeding five million won:
1. A physician, a dentist, an oriental medical doctor, a military doctor, the head of a medical institution, or the head of an institution for confirming infectious pathogens who fails to file a report required under Article 11 or files a false report, regarding Classes 1 and 2 infectious diseases;
2. A person who obstructs filing a report by a physician, a dentist, an oriental medical doctor, a military doctor, the head of a medical institution, or the head of an institution for confirming infectious pathogens under Article 11, regarding Classes 1 and 2 infectious diseases.
[This Article Added on Mar. 27, 2018]
[Moved from Article 79-3 <Mar. 4, 2020>]
 Article 80 (Penalty Provisions)
Any of the following persons shall be punished by a fine not exceeding three million won: <Amended on Mar. 27, 2018; Mar. 4, 2020; Aug. 12, 2020>
1. A physician, a dentist, an oriental medical doctor, a military doctor, the head of a medical institution, the head of an institution for confirming infectious pathogens, or an institution of sentinel surveillance of infectious diseases that fails to file a report required under Article 11 or files a false report, regarding Classes 3 and 4 infectious diseases;
2. A person who obstructs filing a report by a physician, a dentist, an oriental medical doctor, a military doctor, the head of a medical institution, the head of an institution for confirming infectious pathogens, or an institution of sentinel surveillance of infectious diseases under Article 11, regarding Classes 3 and 4 infectious diseases;
2-2. A person who refuses infectious pathogen testing referred to in Article 13 (2);
3. A person who fails to establish infectious disease control facilities, in violation of Article 37 (4);
4. Deleted; <Mar. 4, 2020>
5. A person who fails to comply with a compulsory disposition referred to in Article 42 (excluding persons who refuse hospitalization, quarantine, or isolation prescribed in Article 42 (1), (2) 1, (3), or (7));
6. A person who engages in an occupation involving frequent contact with the general public or who employs patients of an infectious disease, etc. for such occupation, in violation of Article 45;
7. A person who violates any measure taken under Article 47 (excluding subparagraph 3 of that Article) or 49 (1) (excluding matters concerning medical examinations referred to in subparagraphs 2-2 through 2-4 and 3 of that paragraph and subparagraph 14 of that paragraph);
8. A person who renders disinfection services without reporting under Article 52 (1) or after reporting by fraud or other improper means;
9. A person who fails to conduct disinfection in compliance with standards and methods stipulated under Article 54 (1).
 Article 81 (Penalty Provisions)
Any of the following persons shall be punished by a fine not exceeding two million won: <Amended on Jul. 6, 2015; Dec. 3, 2019; Mar. 9, 2021>
1. Deleted; <Mar. 27, 2018>
2. Deleted. <Mar. 27, 2018>
3. A person who neglects to file a report under Article 12 (1);
4. A person who requests a householder, manager, etc., not to file a report under Article 12 (1);
5. Deleted; <Jul. 6, 2015>
6. A person who refuses to comply with an autopsy order issued under Article 20;
7. A person who issues a false certificate of vaccination, in violation of Article 27;
8. A person who refuses, obstructs, or evades an epidemiological investigation, in violation of Article 29;
8-2. Any person who is vaccinated by fraud or other improper means, in violation of Article 32 (2);
9. A person who allows a person who fails to undergo a medical examination for sexually transmitted infectious diseases to engage in business, in violation of Article 45 (2);
10. A person who refuses or evades a medical examination, in violation of Article 46 or 49 (1) 3;
11. A person who fails to comply with a request to provide data prescribed in Article 74-2 (1) or provides false data or who refuses, obstructs, or evades any inspection or inquiry, without good cause.
 Article 81-2 (Aggravated Punishment)
(1) Punishment on a person who commits a crime prescribed in subparagraph 1 of Article 79 in an organized and systematic manner by exhibiting the power of an organization or crowd shall be raised up to one-half of the punishment for the crime.
(2) Where any person transmits an infectious disease to another person by intent or gross negligence by committing a crime provided in the subparagraphs of Article 79-3, the penalty against such crime shall be increased by up to 1/2 of the penalty specified for such crime.
[This Article Added on Mar. 9, 2021]
 Article 82 (Joint Penalty Provisions)
Where the representative of a corporation, or an agent, or employee of or other persons employed by a corporation or an individual commits an offense falling under any of Articles 77 through 81 in relation to affairs of such corporation or individual, not only shall the person who commits such offense be punished but such corporation or individual also shall be punished by a fine under the relevant provisions: Provided, That the foregoing shall not apply where the corporation or the individual has not neglected to pay due attention to or exercise reasonable supervision over the relevant affairs to prevent such offense.
 Article 83 (Administrative Fines)
(1) Any of the following persons shall be subject to an administrative fine not exceeding 10 million won: <Added on Jul. 6, 2015; Dec. 12, 2017; Dec. 3, 2019>
1. A person who fails to report an alteration under the proviso of Article 23 (3) or paragraph (3) of the aforesaid Article;
2. A person who fails to report under Article 23 (5);
3. A person who fails to file a report on modification under the proviso of Article 23-3 (3);
4. A person who makes any false statement, presents any false materials, or intentionally omits or conceals any fact, in violation of Article 35-2.
(2) Any manager or operator who fails to comply with the measures under Article 49 (1) 2-2 shall be subject to an administrative fine not exceeding three million won. <Newly inserted on Aug. 12, 2020>
(3) Any of the following persons shall be subject to an administrative fine not exceeding one million won: <Amended on Jul. 6, 2015; Dec. 3, 2019; Mar. 4, 2020; Aug. 12, 2020>
1. Any person who fails to make a report under Article 28 (2) or has made a false report;
2. A person who fails to file a report under Article 33-3 or files a false report;
2-2. A person who refuses to comply with transfer, etc. prescribed in Article 41 (3);
3. A person who fails to disinfect under Article 51 (3);
4. A person who fails to report the suspension, permanent closure, or reopening of business under Article 53 (1) and (2);
5. A person who fails to keep records of and retain matters concerning disinfection under Article 54 (2) or keeps false records thereof.
(4) Any of the following persons shall be punished by an administrative fine not exceeding 100 thousand won: <Added on Aug. 12, 2020>
1. A user who fails to comply with the measures under Article 49 (1) 2-2 or 2-3;
2. A person who fails to comply with the measures under Article 49 (1) 2-4.
(5) Administrative fines referred to in paragraphs (1) through (4) shall be imposed and collected by the Minister of Health and Welfare, the Commissioner of the Korea Disease Control and Prevention Agency, a competent Mayor/Do Governor, or the head of a competent Si/Gun/Gu, as prescribed by Presidential Decree. <Amended on Jul. 6, 2015; Aug. 11, 2020; Aug. 12, 2020; Jun. 13, 2023>
ADDENDUM <Act No. 9847, Mar. 29, 2009>
Article 1 (Enforcement Date)
This Act shall enter into force one year after the date of its promulgation.
Article 2 (Repeal of Other Statutes)
The Parasitic Disease Prevention Act is hereby repealed.
Article 3 (Applicability to Reporting by Physicians)
The amended provisions of Article 11 shall begin to apply where any of the cases applicable under the amended provisions of Article 11 (1), (3) or (4) first occurs after this Act enters into force.
Article 4 (Applicability to Reporting on Extraction and Transfer of High-Risk Pathogens)
The amended provisions of Article 21 shall begin to apply where a high-risk pathogen is first to be extracted or an already extracted high-risk pathogen is to be transferred after this Act enters into force.
Article 5 (Applicability to Permits for Introducing High-Risk Pathogens into Domestic Environment)
The amended provisions of Article 22 shall begin to apply where a high-risk pathogen is first introduced into the domestic environment after this Act enters into force.
Article 6 (Applicability to Expenses to Be Borne or Subsidized by the State or Local Governments)
The amended provisions of Articles 64 through 68 shall begin to apply to the portion of expenses in the Year 2011 which are to be borne or subsidized by the State and local governments.
Article 7 (General Transitional Measures concerning Dispositions)
An administrative disposition taken pursuant to the former Parasitic Disease Prevention Act and the former Prevention of Contagious Diseases Act, any other act performed by or in relation to an administrative agency as at the time this Act enters into force shall be deemed an act performed by or in relation to an administrative agency under this Act corresponding thereto.
Article 8 (Transitional Measures concerning Contagious Diseases)
A contagious disease under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed an infectious disease under this Act.
Article 9 (Transitional Measures concerning Compensation for Loss Caused by Examinations of Parasitic Diseases)
Compensation for any loss caused by the collection of things pursuant to Article 4 (1) of the former Parasitic Disease Prevention Act before this Act enters into force shall be governed by the former Parasitic Disease Prevention Act.
Article 10 (Transitional Measures concerning Sentinel Surveillance Medical Institutions)
A sentinel surveillance medical institution designated under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed a sentinel surveillance institution designated under the amended provisions of Article 16.
Article 11 (Transitional Measures concerning Vaccination Certificates)
A vaccination certificate under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed a vaccination certificate under the amended provisions of Article 27.
Article 12 (Transitional Measures concerning Vaccination Damage Investigative Teams)
A vaccination damage investigative team under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed a vaccination damage investigative team under the amended provisions of Article 30.
Article 13 (Transitional Measures concerning Designation of Contagious Disease Prevention Facilities)
Any contagious disease prevention facilities establish by a Mayor/Do Governor or the head of a Si/Gun/Gu, or designated by the Minister of Health, Welfare and Family Affairs pursuant to the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed designated as an infectious disease control institution under the amended provisions of Article 36.
Article 14 (Transitional Measures concerning Reporting on Disinfection Services)
(1) A report on disinfection services filed under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed a report on disinfection services filed under the amended provisions of Article 52 (1).
(2) A report on the suspension, closure or reopening of disinfection services filed under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed a report on disinfection services filed under the amended provisions of Article 53.
Article 15 (Transitional Measures concerning Training for Disinfection Service Providers)
A disinfection service provider or his or her employee engaged in disinfection services who has received training under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed to have received training under the amended provisions of Article 55.
Article 16 (Transitional Measures concerning Providing Disinfection Services on Behalf of Others)
A disinfection service provider who provides disinfection services on behalf of others in accordance with the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed to have executed disinfection services on behalf of others under the amended provisions of Article 56.
Article 17 (Transitional Measures concerning Disease Control Officers)
A disease control officer, quarantine inspection commissioner, or disease prevention commissioner under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed a disease control officer, quarantine inspection commissioner, or disease prevention commissioner under the amended provisions of Articles 60 through 62.
Article 18 (Transitional Measures concerning the Parasite Disease Prevention Association)
(1) The Parasitic Disease Prevention Association established under the former Parasitic Disease Prevention Act as at the time this Act enters into force shall be deemed the Korea Association of Health Promotion under the amended provisions of Article 63.
(2) The name of the Parasitic Disease Prevention Association indicated in the register or any other official book as at the time this Act enters into force shall be deemed the name of the Korea Association of Health Promotion under the amended provisions of Article 63.
Article 19 (Transitional Measures concerning Compensation by the State for Injury Caused by Vaccination)
A person who has applied for compensation for injury caused by vaccination, etc. under the former Prevention of Contagious Diseases Act as at the time this Act enters into force shall be deemed to have filed a claim for compensation under the amended provisions of Article 71.
Article 20 (Transitional Measures concerning Penalty Provisions)
The application of penalty provisions to any act committed before this Act enters into force shall be governed by the former Parasitic Disease Prevention Act and the former Prevention of Contagious Diseases Act.
Article 21 Omitted.
Article 22 (Relationship to Other Statutes or Regulations)
A citation of the former Parasitic Disease Prevention Act or the former Prevention of Contagious Diseases Act, or the provisions thereof in other statutes or regulations as at the time this Act enters into force shall be deemed a citation of this Act or the corresponding provisions of this Act, if any, in lieu of the former provisions.
ADDENDA <Act No. 9932, Jan. 18, 2010>
Article 1 (Enforcement Date)
This Act shall enter into force two months after the date of its promulgation. (Proviso Omitted.)
Articles 2 through 5 Omitted.
ADDENDA <Act No. 10789, Jun. 7, 2011>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation. (Proviso Omitted.)
Articles 2 through 6 Omitted.
ADDENDUM <Act No. 11439, May. 23, 2012>
This Act shall enter into force six months after the date of its promulgation.
ADDENDUM <Act No. 11645, Mar. 22, 2013>
This Act shall enter into force six months after the date of its promulgation.
ADDENDUM <Act No. 12444, Mar. 18, 2014>
This Act shall enter into force six months after the date of its promulgation.
ADDENDUM <Act No. 13392, Jul. 6, 2015>
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of Articles 2, 4 through 7, 14, 16 through 18, 34, 46, 47, 49, 50, 67, and 74-2 shall enter into force on the date of its promulgation.
ADDENDA <Act No. 13474, Aug. 11, 2015>
Article 1 (Enforcement Date)
This Act shall enter into force one year after the date of its promulgation.
Articles 2 through 35 Omitted.
ADDENDA <Act No. 13639, Dec. 29, 2015>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of subparagraph 6 of Article 64 and subparagraph 6 of Article 65 shall enter into force on January 1, 2016; and the amended provisions of Articles 76-2 and 79-2 shall enter into force on January 7, 2016.
Article 2 (Preparatory Activities for Establishing Infectious Disease Hospitals)
The Minister of Health and Welfare may engage in preparatory activities necessary to establish an infectious disease hospital under Article 8-2, including appointment of its head, before this Act enters into force. In such cases, the Minister of Health and Welfare may request necessary cooperation from the head of a relevant central administrative agency, the head of a local government, a national or public hospital, a public health clinic, a private medical facility, and any other public organization and relevant expert.
Article 3 (Preparatory Activities for Compensation for Losses)
If deemed necessary for compensation for losses under this Act, the Minister of Health and Welfare, a Mayor/Do Governor, or the head of a Si/Gun/Gu may perform the following activities before this Act enters into force:
1. Taking measures necessary to apply for, determine, and pay compensation for losses under the amended provisions of Article 70;
2. Engaging in preparatory activities for constituting and operating a Deliberation Committee, and requesting interested parties to submit data under the amended provisions of Article 70-2.
Article 4 (Applicability to Methods of Funeral for the Deceased)
The amended provisions of Article 20-2 shall begin to apply to the first death of a patient of an infectious disease, etc. after this Act enters into force.
Article 5 (Applicability to Employer’s Obligation to Cooperate)
The amended provisions of Article 41-2 shall also apply to any employer who has granted a paid leave to an employee hospitalized, quarantined, or isolated under this Act, in relation with Middle East Respiratory Syndrome (MERS) mentioned in subparagraph 5 (s) of Article 2, before this Act enters into force.
Article 6 (Applicability to Compensation for Losses)
The amended provisions of Article 70 shall also apply to any person who has suffered from a loss due to Middle East Respiratory Syndrome (MERS) mentioned in subparagraph 5 (s) of Article 2, before this Act enters into force.
Article 7 (Applicability to Subsidization to Medical Persons and Patients of Infectious Disease)
The amended provisions of Articles 70-3 and 70-4 shall also apply where subsidization is necessary due to Middle East Respiratory Syndrome (MERS) mentioned in subparagraph 5 (s) of Article 2, before this Act enters into force.
Article 8 (Applicability to Double Support)
Where compensation for losses is made or subsidization is provided under the amended provisions of Article 70 or 70-3, any person who has already received a similar compensation or subsidization due to Middle East Respiratory Syndrome (MERS) mentioned in subparagraph 5 (s) of Article 2 as at the time this Act enters into force, shall receive the compensation or subsidization except the amount of compensation or support already provided.
ADDENDA <Act No. 14286, Dec. 2, 2016>
Article 1 (Enforcement Date)
This Act shall enter into force one year after its promulgation: Provided, That ... <omitted> ... Article 3 (1) and (3) of Addenda shall enter into force on May 30, 2017.
Article 2 Omitted.
Article 3 Omitted.
ADDENDUM <Act No. 14316, Dec. 2, 2016>
This Act shall enter into force six months after the date of its promulgation.
ADDENDA <Act No. 15183, Dec. 12, 2017>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation.
Article 2 (Transitional Measures concerning Permission for and Reporting on Establishment and Operation of Facilities Handling High-Risk Pathogens)
If a person has obtained permission for or filed a report on the establishment and operation of a facility handling high-risk pathogens from or with the Director of the Korea Disease Control and Prevention Agency, or a person engaging in examining, preserving, controlling, and transferring high-risk pathogens has obtained permission for or filed a report on the establishment and operation of a research facility under Article 22 (1) of the Transboundary Movement, etc. of Living Modified Organisms Act, pursuant to the previous provisions as at the time this Act enters into force, he or she shall be deemed to have obtained permission or filed a report under the amended provisions of Article 23 (2).
ADDENDA <Act No. 15534, Mar. 27, 2018>
Article 1 (Enforcement Date)
This Act shall enter into force on January 1, 2020: Provided, That the amended provisions of Articles 8-5, 10, and 37 (5) shall enter into force on the date of its promulgation; and the amended provisions of Articles 21, 24, 27 (1), 28 (1) and 39-3, subparagraph 3-2 of Article 65, subparagraph 7-2 of Article 67, and Articles 70 (1) 1-2 and 74-2 (1), and Article 2 (5) of the Addenda, shall enter into force six months after the date of its promulgation.
Article 2 Omitted.
ADDENDA <Act No. 15608, Apr. 17, 2018>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation.
Articles 2 through 7 Omitted.
ADDENDA <Act No. 16101, Dec. 31, 2018>
Article 1 (Enforcement Date)
This Act shall enter into force on January 1, 2019. (Proviso Omitted.)
Articles 2 through 11 Omitted.
ADDENDA <Act No. 16725, Dec. 3, 2019>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of Article 9 (2) 6-2 and 6-3, Article 33-2, and subparagraph 6-2 of Article 67 shall enter into force on the date of its promulgation; the amended provisions of the latter part of Article 10 (2) shall enter into force three months after the date of its promulgation; and the amended provisions of subparagraph 3 (u) of Article 2 of the Infectious Disease Control and Prevention Act (Act No. 15534) shall enter into force on July 1, 2020.
Article 2 (Transitional Measures concerning Composition of the Committee)
(1) Where the amended provisions of the latter part of Article 10 (2) are not complied with as at the time of appointing or commissioning members of the Committee after this Act enters into force, persons who are not a public official shall be commissioned as a member until the relevant amended provisions are satisfied.
(2) The former provisions shall apply to the composition of the Committee until the amended provisions of the latter part of Article 10 (2) are complied with pursuant to paragraph (1).
ADDENDA <Act No. 17067, Mar. 4, 2020>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation: Provided, That the following provisions shall enter into force on the relevant respective dates classified as follows:
1. The amended provisions of Articles 2, 11 (1), 13, 16-2 (1), 22, 23, 23-2, 34-2, 40-3, 42, 47, 49, 52 (2) through (4), 53, 59, 60, 60-3 (limited to the part pertaining to the head of a Si/Gun/Gu), 76-2, and 76-3; subparagraphs 3 and 5 of Article 79; and Article 83 (2) 3: The promulgation date of this Act;
2. The amended provisions of Articles 7, 49-2, 51, 52 (1), 56, and 76-4; and the amended provisions of Article 83 (2) 3 of the Infectious Disease Control and Prevention Act (Act No. 16725): Three months after the promulgation date of this Act;
3. The amended provisions of Articles 21, 23, and 77, and subparagraph 2-2 of Article 79 of the Infectious Disease Control and Prevention Act (Act No. 16725): June 4, 2020;
4. The amended provisions of Articles 77, 79-3, 79-4, and 80: One month after the promulgation date of this Act.
Article 2 (Transitional Measures concerning Epidemiological Investigation Officers)
The epidemiological investigation officers assigned by a Mayor/Do Governor in a Si/Gun/Gu under the former provisions as at the time this Act enters into force shall be deemed epidemiological investigation officers appointed by the head of a Si/Gun/Gu under the amended provisions of Article 60-2.
ADDENDA <Act No. 17472, Aug. 11, 2020>
Article 1 (Enforcement Date)
This Act shall enter into one month after the date of its promulgation: Provided, That ... the amended provisions of any Act, which is amended pursuant to Article 4 of the Addenda and promulgated before this Act enters into force but the enforcement date of which has yet to arrive, shall enter into force on the enforcement date of such Act.
Articles 2 through 5 Omitted.
ADDENDA <Act No. 17475, Aug. 12, 2020>
Article 1 (Enforcement Date)
This Act shall enter into force on the date of its promulgation: Provided, That the amended provisions of Articles 41, 76-3, 79-3, and 83 shall enter into force two months after the date of its promulgation.
Article 2 (Applicability to Expenses Borne by Foreigners)
The amended provisions of Article 69-2 shall apply to foreigners entering Korea after this Act enters into force.
Article 3 (Transitional Measures concerning the Commissioner of the Korea Disease Control and Prevention Agency)
"Commissioner of the Korea Disease Control and Prevention Agency" in the amended provisions of Article 41 (3) and 69-2 shall be construed as "Minister of Health and Welfare" until September 11, 2020.
Article 4 (Transitional Measures concerning Penalty Provisions)
Notwithstanding the amended provisions of Article 41 (2) and subparagraph 2 of Article 79-3, the former provisions shall govern in applying penalty provisions to violations committed before this Act enters into force.
ADDENDUM <Act No. 17491, Sep. 29, 2020>
This Act shall enter into force on the date of its promulgation: Provided, That the amended provisions of Articles 40-5, 49 (3) through (5), 64, 65, 67, and 70-6 shall enter into force three months after the date of its promulgation; and the amended provisions of Article 41 (3) of the Infectious Disease Control and Prevention Act (partially amended by Act No. 17475) shall enter into force on October 13, 2020.
ADDENDA <Act No. 17642, Dec. 15, 2020>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of Article 49-3 shall enter into force on the date of its promulgation.
Article 2 (Applicability to Reporting on Occurrence of Infectious Disease)
The amended provisions of Article 12 (1) 2 and (3) shall begin to apply to the outbreak of an infectious disease required to be reported under the same paragraph after the date this Act enters into force.
Article 3 (Transitional Measures concerning Designation of Facilities for Quarantining Persons Suspected of Contracting Infectious Disease)
Facilities designated as facilities for quarantining contacts before this Act enters into force shall be deemed designated as facilities for quarantining persons suspected of contracting an infectious disease pursuant to the amended provisions of Article 39-3.
ADDENDA <Act No. 17653, Dec. 22, 2020>
Article 1 (Enforcement Date)
This Act shall enter into force on January 1, 2021. <Proviso Omitted>
Articles 2 through 14 Omitted.
ADDENDA <Act No. 17689, Dec. 22, 2020>
Article 1 (Enforcement Date)
This Act shall enter into force on January 1, 2021.
Articles 2 through 8 Omitted.
ADDENDA <Act No. 17893, Jan. 12, 2021.>
Article 1 (Enforcement Date)
This Act shall enter into force one year after the date of its promulgation.
Articles 2 through 23 Omitted.
ADDENDUM <Act No. 17920, Mar. 9, 2021>
Article 1 (Enforcement Date)
This Act shall enter into force on the date of its promulgation: Provided, That the amended provisions of Articles 34 and 49-2 shall enter into force six months after the date of its promulgation.
Article 2 (Transitional Measures concerning Special Cases concerning Purchase of Vaccines and Medicines under Development in Preparation for Infectious Diseases Spread through Bioterrorism)
Contracts necessary for the purchase and supply of vaccine or medicines in development in preparation for a pandemic of infectious diseases spread through bioterrorism and other infectious diseases before this Act enters into force shall be deemed contracts concluded under the amended provisions of Article 40-6.
Article 3 (Applicability to Compensation for Damage)
The amended provisions of Article 72-2 shall begin to apply where a person spreads an infectious disease or increases the likelihood of spread of an infectious disease in violation of this Act after this Act enters into force.
ADDENDA <Act No. 18507, Oct. 19, 2021>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of Article 8-2 shall enter into force on the date of its promulgation.
Article 2 (Applicability to Revocation of Permission for Introduction of High-Risk Pathogens)
(1) The amended provisions of Article 22 (4) 1 and 3 shall also apply to violations committed before this Act enters into force.
(2) The amended provisions of Article 22 (4) 2 shall also apply to the cases where a person who obtained permission for introducing high-risk pathogens before this Act enters into force fails to report on the acquisition within one year after this Act enters into force.
Article 3 (Applicability to Destruction of High-Risk Pathogens)
The amended provisions of Article 23-2 (2) and (3) shall also apply to high-risk pathogens possessed by a person whose permission for the facilities handling high-risk pathogens is revoked or who is ordered to close the facilities handling high-risk pathogens as at the time this Act enters into force.
Article 4 (Applicability to Revocation of Permission for Possession of Infectious Pathogens Spread through Bioterrorism)
The amended provisions of Article 23-3 (4) shall also apply to a person who has obtained permission for possessing infectious pathogens spread through bioterrorism by fraud or other improper means before this Act enters into force.
ADDENDUM <Act No. 18603, Dec. 21, 2021>
This Act shall enter into force three months after the date of its promulgation.
ADDENDA <Act No. 18744, Jan. 11, 2022>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation.
Article 2 Omitted.
ADDENDUM <Act No. 18893, Jun. 10, 2022>
This Act shall enter into force six months after the date of its promulgation.
ADDENDA <Act No. 19213, Jan. 17, 2023>
Article 1 (Enforcement Date)
This Act shall enter into force one year after the date of its promulgation.
Articles 2 through 6 Omitted.
ADDENDUM <Act No. 19290, Mar. 28, 2023>
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of Article 24 (1) shall enter into force three months after the date of its promulgation.
ADDENDUM <Act No. 19419, May 19, 2023>
This Act shall enter into force on the date of its promulgation: Provided, That the amended provisions of Article 33 (2) shall enter into force three months after the date of its promulgation, and the amended provisions of Article 8-6 (4) and (5) shall enter into force six months after the date of its promulgation.
ADDENDUM <Act No. 19441, Jun. 13, 2023>
This Act shall enter into force on the date of its promulgation: Provided, That the amended provisions of Article 2 shall enter into force six months after the date of its promulgation.
ADDENDUM <Act No. 19603, Aug. 8, 2023>
This Act shall enter into force on January 1, 2024: Provided, That the amended provisions of the proviso, with the exception of the items, of subparagraph 5 of Article 2 shall enter into force on the date of its promulgation.
ADDENDA <Act No. 19644, Aug. 16, 2023>
Article 1 (Enforcement Date)
This Act shall enter into force six months after the date of its promulgation.
Articles 2 (Transitional Measures concerning Central Infectious Disease Hospital)
The Central Infectious Disease Hospital designated under previous Article 8-2 (1) before this Act enters into force shall be deemed the Central Infectious Disease Hospital under the amended provisions of that paragraph.
ADDENDA <Act No. 19715, Sep. 14, 2023>
Article 1 (Enforcement Date)
This Act shall enter into force three months after the date of its promulgation: Provided, That the amended provisions of Article 18-5 shall enter into force one year after the date of promulgation, and the amended provisions of Articles 34 (2), 65 and 67 shall enter into force on January 1, 2024.
Article 2 (Applicability to Request for Tests)
The amended provisions of Article 29-2 (1) shall begin to apply where a medical personnel or the head of a medical institution requests the Commissioner of the Korea Disease Control and Prevention Agency to conduct tests on adverse reactions after this Act enters into force.
ADDENDUM <Act No. 20090, Jan. 23, 2024>
This Act shall enter into force six months after the date of its promulgation: Provided, That the amended provisions of Article 24 (3) shall enter into force three months after the date of its promulgation.